<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://triallo.eu</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/search</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/contact</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/privacy-policy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/terms-of-service</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/post-trial-access</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/active-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/non-experimental</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/investigational</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/cost-reimbursement</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/benefits/remote-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/duration/less-than-three-months</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/duration/three-to-six-months</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/duration/six-to-twelve-months</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/duration/one-to-two-years</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/duration/more-than-two-years</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/visits/less-than-five-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/visits/six-to-ten-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/visits/eleven-to-fifteen-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/visits/sixteen-to-twenty-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/visits/more-than-twenty-visits</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/intake-methods/oral</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/intake-methods/injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/18f-psma-1007-pet-ct-imaging-for-prostate-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/2-methoxyestradiol-dose-study-in-healthy-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/5-aminolevulinic-acid-5-ala-for-brain-tumors-in-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/abdominal-aortic-aneurysm-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/abo-101-for-primary-hyperoxaluria-type-1</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/accelerator-based-bnct-for-head-and-neck-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acd856-safety-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acetic-acid-for-healing-skin-ulcers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acetyl-l-carnitine-for-als-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/achilles-tendinopathy-ngi226-microparticles-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/achondroplasia-infigratinib-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/achondroplasia-long-term-study-of-infigratinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/achondroplasia-transcon-cnp-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/achondroplasia-transcon-cnp-treatment-for-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acne-vulgaris-n-acetyl-ged-0507-34-levo-gel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acp-204-for-alzheimer-s-disease-psychosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acquired-hemophagocytic-syndrome-ruxolitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acromegaly-alxn2420-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acromegaly-debio-4126-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acromegaly-paltusotine-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/actinic-keratosis-5-potassium-hydroxide-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/actinic-keratosis-keramod-gel-vs-aldara-cream</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/actinic-keratosis-sinecatechins-ointment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/activated-t-cells-for-graft-vs-host-disease-after-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-agitation-comparing-new-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-bacterial-prostatitis-fosfomycin-vs-cefixime</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-bacterial-skin-infections-iv-oritavancin-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-brain-injury-apomorphine-and-psilocybin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-cholecystitis-antibiotic-treatment-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-cholecystitis-indocyanine-green-in-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-demyelinating-syndromes-in-children-azathioprine-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-graft-versus-host-disease-siltuximab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-heart-failure-diuretic-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-heart-failure-intra-abdominal-pressure-and-ultrasound-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-heart-failure-treatment-comparison-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-hyperkalemia-comparing-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-inflammation-response-lipopolysaccharides-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-ischemic-stroke-mechanical-thrombectomy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-ischemic-stroke-redasemtide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-kidney-injury-angiotensin-receptor-blocker-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-leukemia-177lu-pentixather-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-leukemia-bleximenib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-lymphoblastic-leukaemia-alltogether-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-mesenteric-ischemia-oral-antibiotics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloblastic-leukemia-daratumumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myelogenous-leukemia-siltuximab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-bleximenib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-bleximenib-venetoclax-and-azacitidine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-cd19-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-chip-aml22-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-cln-049-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-cobicistat-with-venetoclax-and-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-comparing-conditioning-regimens-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-comparing-treatment-regimens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-cpx-351-vs-standard-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-dasatinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-decitabine-and-venetoclax-with-atra</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-eganelisib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-emavusertib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-gemtuzumab-ozogamicin-study-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-gemtuzumab-ozogamicin-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-gilteritinib-vs-midostaurin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-gilteritinib-with-venetoclax-and-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-hydroxyurea-and-valproic-acid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-ivosidenib-azacitidine-and-venetoclax-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-jnj-89853413-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-jnj-90189892-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-ko-539-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-l-annamycin-with-cytarabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-low-intensity-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-mb-dnpm-1-tcr-1-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-midostaurin-and-gemtuzumab-ozogamicin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-molidustat-and-ivosidenib-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-mp0533-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-multi-peptide-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-new-oral-drug-for-idh1-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-new-treatments-for-children-and-adolescents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-nopho-dbh-aml-2012-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-oral-azacitidine-with-gilteritinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-personalized-treatment-based-on-flt3-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-revumenib-with-azacitidine-and-venetoclax</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-rvu120-with-venetoclax</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-sndx-5613-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-sulfasalazine-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-venetoclax-and-azacitidine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-venetoclax-and-azacitidine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-venetoclax-and-azacitidine-with-cusatuzumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-venetoclax-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-venetoclax-vs-intensive-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-vyxeos-and-clofarabine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myeloid-leukemia-ziftomenib-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-myocarditis-ibuprofen-vs-standard-pain-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-pancreatitis-omega-3-fatty-acid-infusion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-progressive-stroke-norepinephrine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-pulmonary-embolism-reduced-dose-thrombolytic-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-pyelonephritis-short-vs-long-antibiotic-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-respiratory-distress-syndrome-prs-ck-storm-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-spinal-cord-injury-ng004-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-vaginal-infection-bgy-1601-vt-tablet</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acute-venous-thromboembolism-anticoagulant-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acyclovir-dosage-for-obese-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/acyclovir-for-icu-patients-with-herpes-simplex-virus-reactivation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adce-d01-for-metastatic-soft-tissue-sarcoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adhd-and-depression-dexamfetamine-formulations-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adhd-treatment-dexamfetamine-formulations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adnexal-torsion-contrast-enhanced-ultrasound-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adp-tilil7-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adpkd-treatment-metformin-vs-tolvaptan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adrenocortical-carcinoma-mitotane-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/adrenomyeloneuropathy-dimethyl-fumarate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-basal-cell-carcinoma-cemiplimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-biliary-cancer-personalized-targeted-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-blood-cancers-kqb198-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-and-gastric-cancers-disitamab-vedotin-with-tucatinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-177lu-lu-neob-with-ribociclib-and-fulvestrant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-arv-471-vs-fulvestrant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-capivasertib-and-fulvestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-capivasertib-with-cdk4-6-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-elacestrant-and-everolimus-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-giredestrant-vs-fulvestrant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-her3-dxd-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-inavolisib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-lasofoxifene-and-abemaciclib-vs-fulvestrant-and-abemaciclib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-patritumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-pf-07220060-with-letrozole</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-pf-07248144-with-fulvestrant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-ribociclib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-rly-2608-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-saruparib-and-camizestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-the-p53-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-breast-cancer-trastuzumab-deruxtecan-vs-cdk4-6-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-azd8205-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-bi-1703880-with-ezabenlimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-bi-1831169-and-anti-pd-1-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-bi-765063-and-bi-770371-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-io102-io103-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-jk06-antibody-drug</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-jnj-87704916-tumor-targeting-virus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-ro7759065-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-sot201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-targeted-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-targeted-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancer-th9619-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-ad-o51-4-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-bi-1808-monoclonal-antibody</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-fs222-antibody-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-kfa115-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-maq-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-testing-iph4502</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cancers-with-braf-mutations-sorafenib-and-trametinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cholangiocarcinoma-futibatinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-clear-cell-renal-carcinoma-digital-monitoring-with-cabozantinib-and-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-colon-cancer-preoperative-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-colorectal-cancer-cetuximab-with-encorafenib-and-binimetinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-colorectal-cancer-folfiri-and-cetuximab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-colorectal-cancer-omtx705-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-colorectal-cancer-pttl-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-cutaneous-squamous-cell-carcinoma-incb099280-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-dedifferentiated-liposarcoma-pemigatinib-and-retifanlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-epithelial-ovarian-cancer-radspherin-r-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-gastric-cancer-18f-alf-fapi-74-pet-ct-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-gastric-cancer-azd0901-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-gastric-cancer-exl01-with-nivolumab-and-folfox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-gastric-cancer-new-drug-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-gep-net-177lu-lu-dota-tate-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-head-and-neck-cancer-tg4050-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-head-and-neck-cancer-volrustomig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-hepatobiliary-cancer-new-immunomodulators</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-high-grade-osteosarcoma-omo-103-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-liver-cancer-bay-3547926-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-liver-cancer-cs1003-with-lenvatinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-liver-cancer-ct-01-and-everolimus-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-abbv-400-and-budigalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-adagrasib-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-amivantamab-and-lazertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-atezolizumab-vs-atezolizumab-plus-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-eftilagimod-alfa-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-lung-cancer-stx-241-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-malignancies-testing-dsb2455</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-eik1001-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-enfortumab-vedotin-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-imc-f106c-plus-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-lifileucel-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-new-treatment-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-regorafenib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-relatlimab-with-nivolumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-ro7276389-and-cobimetinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-tebentafusp-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-melanoma-vusolimogene-oderparepvec-with-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-mesothelioma-pembrolizumab-and-dendritic-cell-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-mtap-null-solid-tumors-amg-193-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-neuroendocrine-cancers-dareontm-7-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-neuroendocrine-carcinomas-enfortumab-vedotin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-clear-cell-kidney-cancer-xl092-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-hodgkins-lymphoma-arv-393-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-bay-2927088-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-bay2927088-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-bnt116-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-cemiplimab-and-bnt116-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-cemiplimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-datopotamab-deruxtecan-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-fianlimab-and-cemiplimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-h1-antihistamine-with-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-jnj-86974680-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-m9140-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-maat033-and-cemiplimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-new-immunotherapy-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-osiboost-2-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-pd-1-inhibitor-with-chemotherapy-and-radiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-rilvegostomig-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-thio-with-cemiplimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-zipalertinib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-small-cell-lung-cancer-zongertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-non-squamous-nsclc-dato-dxd-with-rilvegostomig</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-comparing-immune-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-exl-01-with-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-mcla-129-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-nvl-520-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-nvl-655-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-nsclc-roginolisib-with-dostarlimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-ovarian-cancer-comparing-treatment-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-ovarian-cancer-new-chemotherapy-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-ovarian-cancer-niraparib-alone-vs-niraparib-with-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-ovarian-cancer-relacorilant-with-nab-paclitaxel-and-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-ovarian-cancer-torl-1-23-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-pancreatic-cancer-gemcitabine-and-nab-paclitaxel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-pancreatic-cancer-m9140-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-prame-positive-cancers-imc-p115c-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-prostate-cancer-225ac-psma-trillium-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-prostate-cancer-debio-4228-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-prostate-cancer-jnj-87189401-and-jnj-78278343</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-rare-cancers-domvanalimab-zimberelimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-respiratory-diseases-inhaled-furosemide-and-levodropropizine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-sarcoma-bintrafusp-alfa-and-doxorubicin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-sarcoma-nkg2d-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-sarcomas-pembrolizumab-and-cabozantinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-small-cell-lung-cancer-bi-764532-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-soft-tissue-sarcomas-next-generation-sequencing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-cancers-bay-3498264-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-68ga-ga-dpi-4452-and-177lu-lu-dpi-4452-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-89zr-df-crefmirlimab-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-abbv-400-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-abbv-400-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-adu-1805-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ale-p02-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-alta2618-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-amg-355-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-amivantamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-and-blood-cancer-durvalumab-and-tremelimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-anti-gd2-adc-m3554</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-anv600-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-art0380-oral-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-asp3082-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-atezolizumab-with-eik10001-and-radiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-azd0901-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-azd3470-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-azd8421-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-azd9574-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bgb-58067-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bgb-b3227-and-tislelizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bi-1206-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bms-986340-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bms-986482-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bms986504-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-bt5528-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-cxcr4-pet-tracer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-d3s-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-datopotamab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-debio-0123-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-denikitug-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-df6002-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-do-2-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ds-2243a-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-eftilagimod-alpha-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-eik1004-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ep102-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-first-in-human-study-of-ds-3939a</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-grwd5769-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-gsk5733584-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-gsk5733584-with-anti-cancer-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-gsk5764227-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-gtaexs617-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ide397-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-inca033890-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-incb099280-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-incb123667-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-incb161734-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-inp12-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-iph5301-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-itf3756-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-jnj-87890387</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-kqb198-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ly3962673-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ly4170156-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-m1774-and-plx038-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-m9140-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mcla-158-petosemtamab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mdna11-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mk-1084-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mk-1084-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mk-3120-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-mk-8294-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-moma-313-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-most-plus-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ndi-219216-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-oatd-02-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-odm-212-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-omtx705-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-oric-114-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ose-279-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pas-004-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pf-08046050-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pf-08046054-sgn-pdl1v-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pm534-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pm534-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pm54-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-pm54-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-regn7075-with-cemiplimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-repotrectinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-rezatapopt-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-rmc-6291-and-rmc-6236-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ro7502175-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ro7567132-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-ro7589831-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-s095035-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-saruparib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-selpercatinib-access-program</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-sigvotatug-vedotin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-snv1521-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-star0602-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-stp938-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-stx-478-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-t3p-y058-739-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-tapistry-immuno-oncology-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-targeted-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-testing-ipn01194</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-testing-ipn01195</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-tng462-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-transcon-il-2-b-g-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-tt125-802-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-vert-002-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-vvd130037-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-xon7-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-solid-tumors-yl201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-stage-solid-tumors-jnj-95437446</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-thyroid-and-head-and-neck-cancer-18f-alf-psma-11-pet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-thyroid-cancer-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-triple-negative-breast-cancer-tonic-3-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-tumor-cancer-abbv-cls-484-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-tumors-tils-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/advanced-urothelial-carcinoma-mk-2870-with-enfortumab-vedotin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aggressive-b-cell-non-hodgkin-lymphoma-odronextamab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aggressive-b-cell-non-hodgkin-lymphomas-regn5837-and-odronextamab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aggressive-large-b-cell-lymphoma-golcadomide-after-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aggressive-multiple-sclerosis-stem-cell-transplant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ahus-switching-to-iptacopan-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/al-amyloidosis-teclistamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alagille-syndrome-long-term-study-of-livmarli</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-associated-hepatitis-alpha-1-antitrypsin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-dependence-cbd-and-naltrexone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-dependence-sodium-oxybate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-related-liver-disease-gsk4532990-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-use-disorder-psilocybin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alcohol-use-disorder-sunobinop-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alectinib-dosing-standard-vs-personalized-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alectinib-for-pediatric-alk-fusion-positive-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alk-positive-advanced-lung-cancer-nvl-655-vs-alectinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alk-positive-anaplastic-large-cell-lymphoma-vinblastine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alk-positive-non-small-cell-lung-cancer-chemotherapy-plus-lorlatinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergic-rhinitis-beltavac-r-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergic-rhinitis-new-immunotherapy-for-dust-mite-allergy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergic-rhinitis-new-immunotherapy-for-house-dust-mite-allergy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergic-rhinitis-new-immunotherapy-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergy-relief-sublingual-immunotherapy-for-house-dust-mite-allergies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allergy-vaccine-for-grass-and-cupressaceae-allergies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/allopurinol-for-brain-protection-in-newborns-with-heart-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/almagate-for-heartburn-in-pregnant-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aln-f1202-safety-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alopecia-areata-baricitinib-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alopecia-areata-ritlecitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpelisib-for-lymphatic-malformations-with-pik3ca-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpelisib-for-megalencephaly-capillary-malformation-polymicrogyria-syndrome-mcap</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-1-antitrypsin-deficiency-beam-302-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-1-antitrypsin-deficiency-emphysema-sar447537-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-1-antitrypsin-deficiency-fazirsiran-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-1-antitrypsin-deficiency-prolastin-r-self-infusion-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-1-antitrypsin-deficiency-wve-006-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alpha-thalassemia-luspatercept-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alport-syndrome-dapagliflozin-for-kidney-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/als-and-tia-hyperpolarized-pyruvate-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/als-treatment-eh-301-and-n-acetylcysteine-with-riluzole</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/als-treatment-masitinib-with-riluzole</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alternative-antibiotics-for-resistant-utis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-agitation-masupirdine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-dementia-iti-1284-for-agitation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-and-down-syndrome-aci-24-060-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-donepezil-vs-non-drug-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-efavirenz-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-in-down-syndrome-sleep-and-temperature-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-karxt-karx-ec-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-karxt-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-mk-2214-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-npi-001-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-nsc001-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-pri-002-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-psychosis-acp-204-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-ro7126209-iv-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-rotigotine-and-rivastigmine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-tau-and-amyloid-brain-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-the-explas-study-on-plasma-transfusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimer-s-disease-understanding-tau-spread-and-language-function</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-dimethyl-fumarate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-karxt-for-psychosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-karxt-karx-ec-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-mtx46943-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-ntrx-07-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/alzheimers-disease-trontinemab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amantadine-for-improving-alertness-in-icu-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amg-193-for-advanced-gastrointestinal-and-pancreatic-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amg-193-for-advanced-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amg-193-for-advanced-thoracic-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amlitelimab-effects-on-medication-processing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ampullary-adenocarcinoma-mfolfirinox-vs-gemcitabine-or-capecitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/amyotrophic-lateral-sclerosis-argx-119-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anakinra-for-persistent-respiratory-symptoms-after-covid-19</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anal-cancer-treatment-induction-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anal-high-grade-lesions-sinecatechins-ointment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-avacopan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-lnp023-iptacopan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-pioglitazone-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-prednisone-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-rituximab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-associated-vasculitis-rituximab-with-cyclophosphamide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-vasculitis-corticosteroid-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anca-vasculitis-stopping-immunosuppressive-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/andersen-tawil-syndrome-flecainide-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anemia-in-low-risk-myelodysplastic-syndrome-luspatercept-vs-epoetin-alfa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anemia-treatment-intravenous-iron-for-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anesthesia-in-newborns-propofol-vs-thiopental</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anesthesia-in-young-children-low-dose-vs-standard-sevoflurane</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anesthesia-study-ketamine-vs-propofol-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/angelman-syndrome-gtx-102-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/angiosarcoma-and-undifferentiated-pleomorphic-sarcoma-propranolol-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anifrolumab-for-polymyositis-and-dermatomyositis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anorexia-nervosa-donepezil-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anorexia-nervosa-sertraline-pharmacokinetics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anti-cd19-car-t-cell-therapy-for-autoimmune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anti-infection-drugs-healthy-vs-severely-burned-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anti-nmda-receptor-encephalitis-inebilizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotic-levels-in-pregnant-women-with-twins</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotic-treatment-for-critically-ill-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotics-in-bile-fluid-a-study-for-patients-with-biliary-drainage</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotics-in-cerebrospinal-fluid-a-study-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotics-in-children-with-brain-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antibiotics-single-dose-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anticoagulant-treatments-for-intra-cardiac-thrombus-the-argonaut-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/anticoagulation-strategies-for-ecmo-support</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antiplatelet-therapy-duration-after-tavi</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antiplatelet-therapy-reduction-in-high-bleeding-risk-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antisynthetase-syndrome-cyclophosphamide-vs-tacrolimus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/antithrombotic-therapy-after-aortic-valve-implantation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aortic-stenosis-protamine-for-heart-procedure-safety</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/apathy-after-stroke-brain-pathway-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/apixaban-in-short-bowel-syndrome-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/apl-101-for-advanced-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ar-positive-triple-negative-breast-cancer-bicalutamide-and-abemaciclib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ards-treatment-recombinant-human-plasma-gelsolin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/argx-121-safety-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aro-dux4-for-facioscapulohumeral-muscular-dystrophy-type-1</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/arrhythmic-mitral-valve-prolapse-flecainide-and-metoprolol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/arrhythmogenic-cardiomyopathy-atorvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/arthritis-from-cancer-immunotherapy-tocilizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/artificial-cornea-for-severe-corneal-ulcers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/arv-102-food-and-esomeprazole-interaction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asciminib-roll-over-study-for-leukemia-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asp1570-for-advanced-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aspirin-for-preeclampsia-prevention-in-twin-pregnancies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/aspirin-for-preventing-preeclampsia-in-first-time-pregnant-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-and-copd-gb-0895-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-in-children-qmf149-vs-budesonide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-management-birdie-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-amg-691-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-atuliflapon-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-in-children-salbutamol-vs-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-jnj-95597528</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-povorcitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asthma-treatment-tezepelumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/asymptomatic-heart-failure-treasure-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ataxia-telangiectasia-erydex-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ataxia-telangiectasia-n-acetyl-l-leucine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atenativ-for-congenital-antithrombin-deficiency-during-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atezolizumab-for-muscle-invasive-bladder-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atherosclerosis-psilocybin-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atherosclerotic-cardiovascular-disease-maridebart-cafraglutide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atherosclerotic-cardiovascular-disease-obicetrapib-and-ezetimibe-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-amlitelimab-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-amlitelimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-apg777-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-in-children-abrocitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-in-children-tralokinumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-in-children-upadacitinib-vs-dupilumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-investigational-compounds-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-lebrikizumab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-long-term-study-of-amlitelimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-long-term-study-of-apg777</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-methotrexate-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-methylprednisolone-aceponate-cream</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-methylprednisolone-aceponate-ointment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-personalized-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-pf-07275315-and-pf-07264660</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-ro7790121-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-dermatitis-rocatinlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atopic-eczema-dupilumab-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atorvastatin-for-patients-with-chronic-myeloproliferative-neoplasms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atorvastatin-for-preventing-episodic-migraines</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-abelacimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-after-aortic-valve-surgery-atorvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-after-cabg-anticoagulant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-amiodarone-administration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-amiodarone-dose-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-amiodarone-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-ap31969-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-apixaban-vs-warfarin-in-dialysis-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-colchicine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-dapagliflozin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-early-rhythm-control-therapy-for-stroke-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-flecainide-vs-amiodarone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-iv-flecainide-with-ranolazine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-new-drug-treatment-after-stent-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-prevention-landiolol-hydrochloride</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-rivaroxaban-monotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-semaglutide-for-weight-control</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-stopping-anticoagulants-after-heart-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-warfarin-study-for-dialysis-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atrial-fibrillation-woest-3-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atypical-hemolytic-uremic-syndrome-crovalimab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atypical-hemolytic-uremic-syndrome-long-term-study-of-iptacopan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/atypical-teratoid-rhabdoid-tumors-high-dose-chemotherapy-vs-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autism-spectrum-disorder-sensorimotor-therapy-and-oxytocin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/auto1-treatment-for-pediatric-blood-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-cytopenias-povetacicept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-disease-car-expressing-nk-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-disease-ianalumab-delivery-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-diseases-ublituximab-administration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-diseases-vis171-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-encephalitis-satralizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-hemolytic-anemia-anticoagulation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/autoimmune-uveitis-probiotic-supplement-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/avacopan-for-children-with-active-anca-associated-vasculitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/avapritinib-continued-access-for-previous-study-participants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/avian-influenza-vaccine-immune-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-and-psoriatic-arthritis-ixekizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-east-1-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-filgotinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-imaging-with-technetium-labeled-certolizumab-pegol</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-nsaids-vs-biosimilar-tnf-blockers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/axial-spondyloarthritis-risankizumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/azithromycin-for-hospitalized-children-with-asthma-symptoms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-acute-lymphoblastic-leukemia-azd0486-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-acute-lymphoblastic-leukemia-cd19-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-acute-lymphoblastic-leukemia-inotuzumab-ozogamicin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-acute-lymphoblastic-leukemia-ucart22-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-aggressive-lymphoma-ari0003-cell-infusion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-blood-cancers-azd5492-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-cancer-int2104-infusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-lymphoma-car20-nap-t-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-lymphoma-kite-363-and-kite-753-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-lymphoma-transpocart19-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-lymphoma-valemetostat-tosylate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-bgb-16673-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-car-t-cell-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-exs73565-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-mb-cart2219-1-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-nx-5948-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-oral-abbv-101-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-pit565-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-malignancies-srg-1505-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-bi-1206-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-carcik-cd19-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-glofitamab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-jnj-88998377</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-jnj-90014496</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-loncastuximab-tesirine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphoma-surovatamig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkin-lymphomas-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/b-cell-non-hodgkins-lymphoma-glofitamab-and-obinutuzumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bacterial-brain-abscess-oral-vs-iv-antibiotics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bariatric-surgery-metformin-for-diabetes-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/baricitinib-for-calcium-pyrophosphate-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/baricitinib-for-children-hospitalized-with-covid-19</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/baricitinib-for-uveitis-in-children-with-juvenile-idiopathic-arthritis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/basal-cell-carcinoma-electrochemotherapy-vs-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/basal-cell-carcinoma-tirbanibulin-klisyri-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/basal-cell-carcinomas-patidegib-gel-2</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bcg-vaccination-understanding-immune-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bcg-vaccine-for-radiologically-isolated-syndrome-ris</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bcr-abl1-chronic-myeloid-leukemia-asciminib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bcr-abl1-like-acute-lymphoblastic-leukemia-ponatinib-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bdt272-safety-and-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/becker-muscular-dystrophy-edg-5506-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/behcet-s-syndrome-steroids-plus-anticoagulants-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/behcets-disease-uveitis-adalimumab-vs-tocilizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/benzodiazepine-dependence-stabilizing-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/beta-lactam-antibiotics-precision-dosing-in-critically-ill-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/beta-thalassemia-luspatercept-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bevacizumab-vs-corticosteroids-for-cerebral-radiation-necrosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bhv-7000-for-idiopathic-generalized-epilepsy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bi-3009947-tolerance-and-absorption-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bi-3031185-tolerance-study-in-healthy-men</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bi-3776528-tolerance-study-in-healthy-men</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bi-3804379-tolerance-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bi-3810477-tolerance-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bile-acid-diarrhea-atorvastatin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/biliary-atresia-long-term-study-of-odevixibat</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/biliary-tract-cancer-gap-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/biliary-tract-cancer-ivonescimab-vs-folfox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/biliary-tract-cancer-t-dxd-and-rilvegostomig-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/biliary-tract-cancers-18f-f-fapi-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bimekizumab-for-children-with-moderate-to-severe-plaque-psoriasis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-depression-esketamine-nasal-spray</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-depression-lithium-vs-cariprazine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-depression-new-treatment-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-disorder-low-dose-aspirin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-disorder-type-ii-lithium-vs-lamotrigine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-i-disorder-karxt-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-i-disorder-long-term-safety-of-karxt</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bipolar-mania-lumateperone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/birth-control-study-levonorgestrel-tablet</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bisphosphonate-treatment-for-primary-hyperparathyroidism</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-eg-70-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-emda-mmc-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-erdafitinib-delivery-system-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-intravesical-gemcitabine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-mitomycin-c-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-nadofaragene-firadenovec-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-neoadjuvant-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-new-treatment-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-oncofid-p-b-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-pembrolizumab-and-enfortumab-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-sacituzumab-tirumotecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-treatment-bcg-vs-bcg-emda-mmc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-treatment-chemoablation-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bladder-cancer-v940-and-bcg-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bleeding-treatment-in-thrombocytopenic-patients-format-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-long-term-study-of-zanubrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-treatment-abbv-319-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-treatment-allo-revcar01-t-cd123</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-treatment-ccs1477-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-treatment-ciltacabtagene-autoleucel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancer-treatment-smart101-after-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancers-azd0486-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancers-idp-121-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancers-sonrotoclax-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-cancers-trichostatin-a-dose-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/blood-pressure-response-multi-omics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bloodstream-infections-piperacillin-tazobactam-vs-meropenem</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bomedemstat-for-blood-disorders-safety-and-efficacy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bomedemstat-vs-best-available-therapy-for-essential-thrombocythemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bomedemstat-vs-hydroxyurea-for-essential-thrombocythemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-health-aga2118-for-postmenopausal-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-health-alendronate-discontinuation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-health-cagrilintide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-health-everolimus-and-exercise-for-postmenopausal-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-health-identifying-risks-from-glucocorticoids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bone-infections-clindamycin-and-cefalexin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/borderline-personality-disorder-and-adhd-bi-3031185-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botox-for-hidradenitis-suppurativa-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botox-for-inability-to-belch</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botox-for-masseter-muscle-prominence</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botox-r-for-preventing-pancreatic-fistula-after-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botulinum-toxin-for-spastic-equinovarus-in-stroke-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botulinum-toxin-treatment-patient-satisfaction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/botulinumtoxin-a-for-myofascial-pain-in-temporomandibular-disorders</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bowel-dysfunction-after-rectal-cancer-surgery-irrigation-vs-suppositories</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bp1-15205-new-oral-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bp1-7881-safety-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/braf-alterations-in-cancer-fore8394-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/braf-mutated-melanoma-encorafenib-and-binimetinib-with-cemiplimab-and-fianlimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/braf-v600e-mutant-metastatic-colorectal-cancer-brave-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/braf-v600e-mutated-metastatic-colorectal-cancer-encorafenib-and-folfiri</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-aneurysms-acetylsalicylic-acid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-disorders-nt-0150-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-health-11c-hsp990-pet-imaging</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-health-5-ht2a-receptor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-injury-and-concussion-tau-tracer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-injury-effects-of-ketamine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-metastases-detection-pet-dopa-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-radionecrosis-bevacizumab-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-surgery-pain-management-nerve-block-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brain-tumor-treatment-bi-764532-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brca-related-metastatic-breast-cancer-pembrolizumab-and-carboplatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-abemaciclib-with-endocrine-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-alisertib-with-hormone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-diagnosis-contrast-enhanced-spectral-mammography</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-elacestrant-vs-standard-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-fezolinetant-for-hot-flashes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-genomics-guided-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-gr1014-gel-for-radiation-skin-protection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-inavolisib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-lower-dose-of-cdk-4-6-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-mk-2870-with-or-without-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-new-eye-safety-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-nivolumab-and-novel-immunotherapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-palbociclib-and-fulvestrant-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-palbociclib-and-fulvestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-patritumab-deruxtecan-vs-standard-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-patritumab-deruxtecan-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-personalized-treatment-with-capivasertib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-prevention-denosumab-for-women-with-brca1-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-prevention-exemestane-vs-tamoxifen</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-related-lymphedema-topical-tacrolimus-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-ribociclib-with-hormone-therapy-and-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-shorter-hormone-therapy-duration</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-stopping-cdk4-6-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-study-of-oki-219-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-surgery-icg-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-surgery-ketorolac-and-pregabalin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-trastuzumab-deruxtecan-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-chemotherapy-vs-endocrine-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-elacestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-elacestrant-with-olaparib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-for-women-70-radiation-vs-hormone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-fulvestrant-with-palbociclib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-i-bct-1-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-op-1250-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-sac-tmt-vs-standard-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-treatment-tucatinib-and-capecitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-typology-based-coaching-with-ribociclib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-cancer-vepdegestrant-and-samuraciclib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-imaging-iodine-contrast-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-mri-low-dose-gadolinium-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-reconstruction-goal-directed-fluid-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/breast-reconstruction-surgery-opioid-free-vs-opioid-based-anesthesia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brexucabtagene-autoleucel-for-rare-b-cell-malignancies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brigatinib-for-pediatric-and-young-adult-alk-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/brivaracetam-for-childhood-absence-epilepsy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bronchiectasis-7-hypertonic-saline-inhalation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bronchiectasis-comparing-antibiotic-treatments-for-pa-infection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bronchiectasis-inhaled-antibiotics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bronchiectasis-long-term-study-of-bi-1291583</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/bronchopulmonary-dysplasia-stem-cell-treatment-for-preterm-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/budesonide-for-inflammation-in-functional-dyspepsia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/buprenorphine-for-severe-suicidal-thoughts-in-major-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/burn-patients-antibiotic-use-before-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/burn-treatment-in-children-new-skin-graft-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/burning-mouth-syndrome-clonazepam-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/buspirone-for-weak-esophageal-motility</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/c3-glomerulopathy-aliskiren-vs-enalapril</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/c3-glomerulopathy-and-icgn-oms906-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/c3-glomerulopathy-iptacopan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/c3-glomerulopathy-testing-cpv-104</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cabergoline-for-episodic-migraine-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/caffeine-treatment-for-early-alzheimer-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/caix-positive-cancer-68ga-oncocaix-imaging-agent</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/calcific-aortic-valve-stenosis-pelacarsen-tqj230-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/calcium-absorption-glycocholate-and-butyrate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/calr-mutated-myeloproliferative-neoplasms-jnj-88549968-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-anorexia-art27-13-cannabinoid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-detection-68ga-fapi-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-imaging-18f-alf-fapi-74-pet-ct</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-imaging-geh200520-and-geh200521-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-imaging-new-non-invasive-technique</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-pain-management-paracetamol-with-opioids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-prevention-in-lynch-syndrome-dendritic-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-study-ly3537982-for-kras-g12c-mutant-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-abp-234-vs-keytruda</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-continuation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-decitabine-and-cedazuridine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-enhancing-radionuclide-therapy-with-parp-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-evaluating-cc-486-in-liver-impairment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-hro761-for-specific-genetic-changes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-imipramine-for-fascin1-overexpression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-immune-markers-and-side-effects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-immune-therapy-with-ultrasound</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-long-term-study-of-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-nextgen-til-act-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-ntx-1088-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatment-pet-tracers-and-t-cell-activity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cancer-treatments-impact-on-speech-and-quality-of-life</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/candidiasis-treatment-mecloderm-r-cream-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cangrelor-for-acute-ischemic-stroke-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cannabidiol-for-refractory-childhood-epilepsy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cannabinoids-for-quality-of-life-in-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/capsaicin-for-finger-pain-in-osteoarthritis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-therapy-for-acute-leukemia-in-young-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-therapy-for-autoimmune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-therapy-for-blood-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-therapy-for-severe-autoimmune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-therapy-understanding-extracellular-vesicles</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car-t-cell-treatment-for-high-risk-mantle-cell-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/car123-t-cell-therapy-for-blood-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carbetocin-nasal-spray-for-hunger-in-prader-willi-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carcinoid-syndrome-paltusotine-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carcinoma-of-unknown-primary-18f-f-fapi-pet-ct-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-al-amyloidosis-18f-florbetaben-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-al-amyloidosis-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-amyloidosis-pet-imaging-with-vizamyl-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-anesthesia-eleveld-model-for-propofol-and-remifentanil</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-arrest-amiodarone-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-arrest-and-ventricular-fibrillation-rime-ivf-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-arrest-ketamine-vs-propofol-sedation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-arrest-landiolol-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-device-implantation-local-vs-regional-anesthesia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-surgery-angiotensin-ii-vs-noradrenaline</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-surgery-dexamethasone-and-olanzapine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-surgery-doac-vs-vitamin-k-antagonist-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-surgery-fibrinogen-concentrate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiac-surgery-vasopressin-vs-norepinephrine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardio-renal-syndrome-peritoneal-ultrafiltration-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiogenic-shock-beta-receptor-modulation-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiogenic-shock-early-empagliflozin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiogenic-shock-levosimendan-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-collapse-vasopressor-use-during-intubation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-disease-gene-analysis-for-statin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-disease-low-dose-rivaroxaban-in-advanced-ckd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-disease-new-care-strategies-for-type-1-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-disease-prevention-personalized-statin-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-health-in-type-2-diabetes-colcot-t2d-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-risk-allopurinol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-risk-management-bio-risk-event-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cardiovascular-safety-bi-456906-for-overweight-individuals</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cariprazine-for-adolescents-with-schizophrenia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carotid-artery-disease-18f-alf-nota-octreotide-pet-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carotid-stenosis-ficolin-2-and-inflammation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carpal-tunnel-syndrome-injection-vs-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cart-cell-therapy-for-acute-lymphoblastic-leukemia-in-young-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cart19-cells-for-blood-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cart84-treatment-for-relapsed-acute-leukemias</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/carvedilol-vs-flecainide-for-ventricular-arrhythmias</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/caspofungin-for-icu-yeast-infections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/castrate-resistant-prostate-cancer-acetylsalicylic-acid-and-atorvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/castration-resistant-prostate-cancer-cc-1-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/castration-resistant-prostate-cancer-darolutamide-with-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/castration-resistant-prostate-cancer-lutetium-177lu-vipivotide-tetraxetan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cataract-surgery-clobetasol-vs-prednisolone-in-young-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cataract-surgery-preoperative-nsaids-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cbd-for-alcohol-use-disorder-a-phase-ii-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cd19-lymphoid-disease-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cd20-positive-acute-lymphoblastic-leukemia-obinutuzumab-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cd30-positive-lymphoma-brentuximab-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cdr404-for-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ceb-01-for-pediatric-abdominal-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cefiderocol-in-peritoneal-dialysis-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ceftazidime-avibactam-for-critically-ill-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/celiac-disease-amlitelimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cell-therapy-for-acute-kidney-injury-after-heart-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cell-therapy-for-amyotrophic-lateral-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cemiplimab-and-imiquimod-for-high-risk-basal-cell-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cemiplimab-for-advanced-adrenocortical-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cemiplimab-for-high-risk-skin-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cenerimod-bioavailability-study-in-healthy-men</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/central-retinal-artery-occlusion-tenecteplase-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebral-adrenoleukodystrophy-leriglitazone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebral-amyloid-angiopathy-aln-app-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebral-amyloid-angiopathy-new-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebral-palsy-incobotulinumtoxina-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebrolysin-for-cadasil-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebrolysin-for-recovery-after-ischemic-stroke</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cerebrospinal-fluid-disorders-mri-contrast-agent-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-cancer-fertility-sparing-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-cancer-ithaca-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-cancer-relatlimab-and-nivolumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-cancer-surgery-plus-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-cancer-volrustomig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-dysplasia-improving-diagnosis-with-estrogen</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-dystonia-botulinum-toxin-for-back-muscle-activity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cervical-dystonia-ipn10200-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chemotherapy-and-immunotherapy-for-pancoast-tumor-in-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chemotherapy-dose-adjustment-for-dpd-deficient-gastrointestinal-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chemotherapy-for-standard-risk-adult-medulloblastomas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chemotherapy-induced-peripheral-neuropathy-capsaicin-patch-vs-duloxetine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chemotherapy-induced-polyneuropathy-aconite-pain-oil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chf10073-inhaled-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chickenpox-vaccine-safety-study-for-young-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chickenpox-vaccine-study-for-children-aged-12-to-15-months</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chikungunya-vaccine-effectiveness-and-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-absence-epilepsy-brivaracetam-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-cancer-vaccine-response-study-for-measles-and-chickenpox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-epilepsy-perampanel-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-leukemia-inotuzumab-ozogamicin-vs-allr3</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-onset-nephrotic-syndrome-obinutuzumab-vs-mmf</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/childhood-renal-tumors-comparing-chemotherapy-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/children-s-experience-after-general-anesthesia-sedation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-chemo-and-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-comparing-rfa-and-pdt-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-ivosidenib-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-ivosidenib-with-durvalumab-and-gemcitabine-cisplatin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-sirt-and-capecitabine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholangiocarcinoma-tinengotinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholestatic-pruritus-linerixibat-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholestatic-pruritus-maralixibat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholestatic-pruritus-volixibat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholesterol-management-fixed-dose-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholesterol-management-rosuvastatin-10-mg</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cholestyramine-for-obese-women-pollutant-levels-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/choline-alfoscerate-for-elderly-with-subthreshold-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/choline-chloride-for-injection-in-intestinal-failure</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chondrosarcoma-ivosidenib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/choroidal-melanoma-belzupacap-sarotalocan-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-cluster-headache-botulinum-toxin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-cluster-headache-low-dose-lsd-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-coccygodynia-capsaicin-8-patches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-constipation-lecicarbon-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-cough-taplucainium-inhalation-powder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-cutaneous-lupus-erythematosus-anifrolumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-depression-ketamine-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-dialysis-patiromer-for-potassium-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-graft-versus-host-disease-axatilimab-and-ruxolitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-graft-versus-host-disease-axatilimab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-graft-versus-host-disease-axatilimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hdv-infection-tobevibart-and-elebsiran-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-heart-failure-combined-diuretic-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-heart-failure-cor-1167-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-heart-failure-ferric-derisomaltose-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-heart-failure-omecamtiv-mecarbil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-heart-failure-vitamin-d-and-oral-iron-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hepatitis-b-long-term-study-on-treatment-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hepatitis-d-bulevirtide-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hepatitis-delta-bjt-778-vs-bulevirtide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hepatitis-delta-brelovitug-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hypertension-in-pregnancy-aspirin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-hypoparathyroidism-eneboparatide-azp-3601</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-immune-thrombocytopenia-kedrion-ivig-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-immune-thrombocytopenia-mezagitamab-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-infection-in-hip-and-knee-implants-68ga-pet-ct-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-and-fibrotic-diseases-68gallium-fapi-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-bowel-disease-intravenous-lidocaine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-demyelinating-polyneuropathy-batoclimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-demyelinating-polyneuropathy-dnth103-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-demyelinating-polyneuropathy-riliprubart-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-demyelinating-polyneuropathy-riliprubart-vs-ivig</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-demyelinating-polyradiculoneuropathy-tak-881-vs-hyqvia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-inflammatory-diseases-low-dose-interleukin-2-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-amiloride-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-baxdrostat-with-dapagliflozin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-bi-690517-with-empagliflozin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-camostat-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-ckd-biomatch-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-dapagliflozin-and-balcinrenone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-finerenone-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-finesse-study-on-albuminuria-reduction</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-in-children-finerenone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-optimizing-tacrolimus-dosage-with-genetic-testing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-patiromer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-sevuparin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-teriparatide-for-bone-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-ultra-sensitive-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-kidney-disease-vicadrostat-and-empagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-limb-threatening-ischemia-bone-marrow-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-low-back-pain-antibiotic-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-low-back-pain-melatonin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-low-back-pain-stem-cell-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-low-back-pain-tricortin-1000-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lung-allograft-dysfunction-belumosudil-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lung-disease-in-premature-babies-ohb-607-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-abbv-453-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-acalabrutinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-acalabrutinib-vs-venetoclax</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-apg-2575-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-bgb-16673-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-cap-100-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-ibrutinib-and-obinutuzumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-intermittent-ibrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-lisaftoclax-and-acalabrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-lisaftoclax-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-mosunetuzumab-and-pirtobrutinib-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-mosunetuzumab-and-venetoclax-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-nemtabrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-new-triple-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-pirtobrutinib-vs-ibrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-tailored-ibrutinib-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-venetoclax-and-acalabrutinib-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-venetoclax-and-epcoritamab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-venetoclax-and-obinutuzumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-venetoclax-and-pirtobrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-venetoclax-with-ibrutinib-and-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-lymphocytic-leukemia-zanubrutinib-and-obinutuzumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-atorvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-cgrp-monoclonal-antibody-and-botox-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-dysport-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-eptinezumab-for-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-in-adolescents-rimegepant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-migraine-xeomin-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-asciminib-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-asciminib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-elvn-001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-olverembatinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-second-stop-of-tki-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myeloid-leukemia-tern-701-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-myelomonocytic-leukemia-new-treatment-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-obstructive-pulmonary-disease-azd6793-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-obstructive-pulmonary-disease-gsk3862995b-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-obstructive-pulmonary-disease-new-inhaler-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-obstructive-pulmonary-disease-tezepelumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-obstructive-pulmonary-disease-verekitug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-open-angle-glaucoma-preservative-free-bimatoprost-eye-drops</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pain-after-mastectomy-comparing-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pain-in-children-capsaicin-patch-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pain-prevention-duloxetine-for-hernia-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pancreatitis-metamizole-for-pain-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pelvic-pain-esketamine-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-pouchitis-in-children-vedolizumab-iv-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-lebrikizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-mepolizumab-and-nasal-polypectomy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-stopping-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-with-nasal-polyps-dupilumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-with-nasal-polyps-itepekimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-with-nasal-polyps-tapering-biologics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-rhinosinusitis-with-nasal-polyps-tezepelumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-spontaneous-urticaria-and-hidradenitis-suppurativa-inf904-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-spontaneous-urticaria-barzolvolimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-spontaneous-urticaria-bp11-vs-xolair</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-spontaneous-urticaria-omalizumab-treatment-intervals</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-spontaneous-urticaria-remibrutinib-for-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-subdural-hematoma-timing-of-anticoagulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-urticaria-briquilimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-urticaria-study-of-blu-808</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-urticaria-testing-remibrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/chronic-wet-cough-in-children-the-amic-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cidp-nvg-2089-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cidp-riliprubart-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cidp-treatment-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-and-ascites-fecal-microbiota-transfer-capsules</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-and-ascites-personalized-human-albumin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-and-portal-hypertension-metformin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-carvedilol-for-preventing-digestive-bleeding</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-carvedilol-for-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-due-to-nash-mash-efruxifermin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-treatment-albumin-and-enoxaparin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-treatment-efinopegdutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cirrhosis-treatment-pegozafermin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cisternal-lavage-therapy-for-aneurysmal-subarachnoid-hemorrhage</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cit-013-for-inflammatory-mediated-immune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/citalopram-for-reflux-hypersensitivity-and-functional-heartburn</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clear-cell-renal-cell-carcinoma-pet-scan-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clebopride-for-the-treatment-of-rumination-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cleft-palate-treatment-tissue-engineered-oral-mucosa-substitute</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clenbuterol-for-spinal-and-bulbar-muscular-atrophy-sbma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clindamycin-for-infections-impact-of-rifampicin-and-obesity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clofarabine-for-advanced-urothelial-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clonidine-for-preventing-agitation-in-young-children-after-anesthesia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clostridioides-difficile-infection-exl01-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clostridioides-difficile-infection-shorter-vancomycin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/clostridioides-difficile-infection-ve303-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cluster-headache-study-understanding-brain-activity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cmv-prevention-in-lung-transplant-recipients-letermovir-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cns-lymphoma-90y-y-pentixather-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cobolimab-and-dostarlimab-for-pediatric-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cochlear-implant-surgery-testing-vsf1-01-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-and-motor-function-study-donepezil-in-older-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-deficits-in-multiple-sclerosis-modafims-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-disorders-biofinder-2-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-dysfunction-in-schizophrenia-clemastine-and-exercise-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-impairment-in-parkinson-s-donepezil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cognitive-improvement-in-down-syndrome-bumetanide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colchicine-for-angina-in-microvascular-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colchicine-for-heart-and-kidney-health-in-chronic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colchicine-for-heart-health-after-pci</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colchicine-for-knee-and-hip-osteoarthritis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colchicine-for-peripheral-artery-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cold-induced-urticaria-gtx-b001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colifin-r-therapy-for-adults-with-bronchiectasis-and-pseudomonas-infection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colitis-from-cancer-treatment-the-icad-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-chemotherapy-study-for-older-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-dostarlimab-with-capeox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-hipec-with-mitomycin-c-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-neoadjuvant-dostarlimab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-new-treatment-with-pipac</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-personalized-treatment-strategy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colon-cancer-treatment-neo-adjuvant-chemotherapy-for-seniors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colonoscopy-prep-comparing-plenvu-r-and-picoprep-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colonoscopy-prep-mannitol-vs-plenvu-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-abbv-400-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-amivantamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-amivantamab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-cc-3-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-dendritic-cell-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-diagnosis-fapi-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-encorafenib-and-cetuximab-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-fapi-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-flu-vaccine-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-galunisertib-and-capecitabine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-intermittent-vs-continuous-treatment-with-panitumumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-intravenous-iron-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-mk-1084-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-new-immunotherapy-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-new-treatment-with-5-fluorouracil-panitumumab-and-sotorasib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-nilk-2301-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-pd-l-506-oral-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-pipac-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-post-surgery-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-prevention-mesalamine-for-lynch-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-reduced-dose-chemotherapy-for-older-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-ro7198457-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-sgm-101-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-stc-1010-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-telisotuzumab-adizutecan-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-temozolomide-and-irinotecan-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-cancer-unicorn-study-on-targeted-preoperative-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-liver-metastases-haip-syst-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-liver-metastases-ip-001-immuno-adjuvant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-liver-metastases-sgm-101-and-indocyanine-green-imaging</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-polyp-removal-anticoagulants-and-antiplatelets-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-polypectomy-anticoagulation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/colorectal-surgery-cefoxitin-administration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/combination-therapies-for-advanced-esophageal-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/community-acquired-pneumonia-amoxicillin-vs-amoxicillin-clavulanate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/community-acquired-pneumonia-customized-antibiotic-duration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/community-acquired-pneumonia-inhaled-levofloxacin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/comparing-pb016-to-entyvio-for-healthy-participants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/complement-3-glomerulopathy-study-of-iptacopan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/complicated-urinary-tract-infections-in-children-vabomere-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/compulsive-sexual-behavior-disorder-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/congenital-hyperinsulinism-hm15136-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/congenital-nephrogenic-diabetes-insipidus-fluconazole-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/congenital-pseudarthrosis-of-the-tibia-nvd003-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/constipation-prevention-in-critically-ill-children-peg3350-e-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/continued-treatment-with-parsaclisib-for-blood-disorders</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-atorvastatin-for-reducing-exacerbations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-dronabinol-for-breathlessness-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-eosinophil-guided-inhaled-corticosteroid-reduction</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-exacerbation-new-diagnostic-strategy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-management-azithromycin-based-on-mucus-properties</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/copd-treatment-understanding-ics-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/corneal-endothelial-transplantation-nsaids-vs-steroids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/corneal-transplantation-optimized-immunosuppression-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-artery-disease-angiolite-stent-and-antiplatelet-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-artery-disease-comparing-diabetes-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-artery-disease-screening-heart-ct-in-type-2-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-artery-disease-syn2-pet-scan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-artery-spasm-testing-bosentan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/coronary-disease-tirzepatide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/corticobasal-syndrome-glycerol-phenylbutyrate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/corticosteroid-treatment-for-acute-myocarditis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/corticosteroids-detection-in-anti-doping-tests</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cortisone-treatment-for-children-with-facial-nerve-palsy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covert-brain-infarction-antiplatelet-and-lipid-lowering-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-booster-cd40-pan-cov-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-ibuzatrelvir-study-for-high-risk-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-treatment-anti-coronavirus-immunoglobulin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-treatment-antiviral-therapy-for-immunocompromised-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-treatment-ltx-109-nasal-spray-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-treatment-nirmatrelvir-ritonavir-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-treatment-recovery-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-vaccine-booster-study-cd40-rbdv</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-vaccine-immunology-study-in-finland</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-vaccine-preventing-type-1-diabetes-in-at-risk-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/covid-19-vaccine-study-bimervax-r-lp-8-1</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cp-506-for-solid-tumors-a-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/craniotomy-pain-management-s-ketamine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crd-4730-for-catecholaminergic-polymorphic-ventricular-tachycardia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crigler-najjar-syndrome-gnt0003-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crimean-congo-hemorrhagic-fever-n-pvax1-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crispr-car-therapy-for-blood-and-solid-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crispr-til-for-metastatic-melanoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/critical-limb-ischemia-l-prf-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crizotinib-for-children-with-severe-type-2-neurofibromatosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crizotinib-safety-study-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crn04894-for-hormonal-imbalance</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-and-colitis-stopping-anti-tnf-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-adalimumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-azd7798-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-cellvizio-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-comparing-biological-therapies-after-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-dual-biological-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-exl01-for-post-surgery-recurrence-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-in-children-budesonide-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-in-children-mirikizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-multi-donor-fecal-microbiota-transfer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-new-cellular-treatment-for-fistulas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-new-treatment-target-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-new-ultrasound-method-with-microbubbles</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-obefazimod-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-risankizumab-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-ro7790121-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-sar441566-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-sar442970-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-tak-279-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-tulisokibart-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-upadacitinib-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-vedolizumab-vs-adalimumab-dose-increase</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohn-s-disease-vedolizumab-with-upadacitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohns-disease-and-ulcerative-colitis-tulisokibart-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohns-disease-azd7798-pet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohns-disease-mirikizumab-with-tirzepatide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohns-disease-morf-057-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crohns-disease-tulisokibart-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/crswnp-predicting-response-to-mepolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cryoglobulinemia-vasculitis-belimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cryptogenic-stroke-stop-trial-on-blood-thinners</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/csl889-for-sickle-cell-disease-a-new-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ctnnb1-syndrome-gene-therapy-study-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cushing-s-disease-silycus-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cushings-disease-lu-ag13909-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cushings-syndrome-fluasterone-buccal-tablet</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cutaneous-lupus-erythematosus-imvt-1402-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cutaneous-lupus-erythematosus-litifilimab-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cutaneous-melanoma-ima203-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cutaneous-t-cell-lymphoma-mogamulizumab-and-skin-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cutibacterium-acnes-infections-rifampicin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystectomy-complications-antifungal-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystectomy-targeted-antibiotic-prophylaxis-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-anakinra-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-inhaled-teicoplanin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-long-term-study-of-bi-3720931-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-nebulized-bacteriophage-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-spl84-inhalation-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-vanzacaftor-tezacaftor-deutivacaftor-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-vx-121-tezacaftor-deutivacaftor-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cystic-fibrosis-vx-522-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytisine-for-quitting-nicotine-in-e-cigarettes-and-tobacco</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytisine-vs-nicotine-replacement-therapy-for-smokers-with-chronic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytomegalovirus-in-pregnancy-valacyclovir-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytomegalovirus-treatment-letermovir-and-valganciclovir-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytoreductive-surgery-albumin-and-ringer-lactate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/cytoreductive-surgery-hipress-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/danicopan-for-pediatric-pnh-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dapagliflozin-for-decompensated-liver-cirrhosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dapagliflozin-for-heart-health-in-amyloid-transthyretin-cardiac-amyloidosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dapagliflozin-for-heart-protection-in-breast-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dapagliflozin-for-patients-undergoing-heart-bypass-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dapansutrile-tablets-for-acute-gout-flare</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/daratumumab-for-monoclonal-gammopathy-of-renal-significance</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/daratumumab-for-myalgic-encephalomyelitis-me-cfs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/daratumumab-for-very-high-risk-t-cell-acute-lymphoblastic-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/daridorexant-for-insomnia-in-alzheimer-s-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/darolutamide-and-bipolar-androgen-therapy-for-advanced-prostate-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/davincy-trial-fos-aprepitant-for-nausea-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/day101-for-pediatric-brain-cancer-and-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dazukibart-for-idiopathic-inflammatory-myopathies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/de-escalating-treatment-for-her2-positive-metastatic-breast-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/debio-1453p-first-in-human-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/decompensated-cirrhosis-new-human-albumin-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/deep-burns-testing-denovoskintm-graft</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/delayed-gastric-emptying-nicotine-patch-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/delayed-sleep-wake-phase-disorder-tasimelteon-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dementia-care-benefits-of-amyloid-pet-imaging</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dementia-new-treatments-for-agitation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dementia-with-lewy-bodies-ambroxol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dengue-vaccine-qdenga-antibody-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/denocharcot-trial-denosumab-for-charcot-foot-in-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/denosumab-for-fibrous-dysplasia-and-mccune-albright-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/denosumab-impact-on-muscle-strength-and-insulin-sensitivity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dent-2-disease-alpelisib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dental-implant-surgery-antibiotics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dental-implants-antibiotic-use-in-bone-augmentation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/depression-pramipexole-for-anhedonia-symptoms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dermatomyositis-and-polymyositis-pf-06823859-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dermatomyositis-baricitinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/desmoid-tumors-nirogacestat-study-for-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/deucravacitinib-for-inflammatory-skin-conditions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/deucravacitinib-for-pediatric-plaque-psoriasis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/deuruxolitinib-safety-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexamethasone-for-advanced-multiple-myeloma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexamethasone-for-congenital-adrenal-hyperplasia-in-pregnancy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexamethasone-for-moderate-to-severe-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexamethasone-for-severe-burns</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexamethasone-for-severe-hospital-acquired-pneumonia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dexmedetomidine-for-pain-management-in-pediatric-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dextroamphetamine-for-amphetamine-dependence-a-clinical-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetes-and-bone-health-alendronate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetes-foot-ulcers-mesenchymal-stem-cells-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-cardiovascular-autonomic-neuropathy-the-fibrocan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-foot-infections-contezolid-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-foot-syndrome-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-foot-ulcers-comparing-two-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-foot-ulcers-phage-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-foot-ulcers-plasma-rich-in-growth-factors-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-ketoacidosis-comparing-ringer-lactate-and-saline</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-kidney-disease-hyperpolarized-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-macular-edema-bi-1815368-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-macular-edema-dexamethasone-implant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-macular-edema-faricimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-macular-edema-fluocinolone-vs-dexamethasone-implants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-neuropathic-pain-incobotulinumtoxin-a-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-retinopathy-bi-764524-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diabetic-retinopathy-coliriobcn070660-eye-drops</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/difelikefalin-for-itching-in-adolescents-on-hemodialysis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/difficult-to-treat-hypertension-optimal-ht-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-cutaneous-systemic-sclerosis-ianalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-acalabrutinib-with-r-minichop</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-axicabtagene-ciloleucel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-epcoritamab-plus-lenalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-epcoritamab-with-r-chop</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-glofitamab-with-gemcitabine-and-oxaliplatin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-loncastuximab-and-epcoritamab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-odronextamab-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-polatuzumab-vedotin-with-r-chp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-rituximab-and-golcadomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-selinexor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-zilovertamab-vedotin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/diffuse-large-b-cell-lymphoma-zilovertamab-vedotin-with-r-chp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dilated-cardiomyopathy-anakinra-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dilated-cardiomyopathy-azd4063-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dilated-cardiomyopathy-candesartan-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dilated-cardiomyopathy-risedronate-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dipg-treatment-study-onc201-vs-everolimus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dipg-treatment-targeted-drug-study-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/distal-radius-fracture-brachial-plexus-nerve-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dlbcl-treatment-dexrazoxane-for-heart-protection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dmt-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dobutamine-for-very-preterm-infants-with-low-blood-flow</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dok7-congenital-myasthenic-syndrome-argx-119-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dopamine-changes-in-depression-escitalopram-vs-bupropion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dopaminergic-pathway-changes-in-comatose-patients-with-traumatic-brain-injury</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dornase-alfa-for-severe-trauma-patients-in-icu</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dostarlimab-for-advanced-cancer-with-dmmr-msi</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dostarlimab-for-untreated-locally-advanced-rectal-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/doxapram-for-preterm-newborns</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dravet-syndrome-epx-100-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/drug-interaction-study-carbamazepine-and-pf-07248144</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/drug-interaction-study-itraconazole-and-azd5004</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/drug-resistance-in-cancer-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/drug-resistant-epilepsy-rapamycin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dry-age-related-macular-degeneration-pst-611-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dry-eye-disease-prgf-eye-drops-for-glaucoma-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ds-1103a-new-combination-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dtap-booster-vaccination-for-health-care-workers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-bmn-351-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-entr-601-44-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-entr-601-45-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-givinostat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-givinostat-study-for-young-boys</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-gnt0004-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-satralizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-sgt-003-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/duchenne-muscular-dystrophy-sqy51-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupilumab-for-chronic-rhinosinusitis-with-nasal-polyps</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupilumab-for-uncontrolled-moderate-to-severe-asthma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupilumab-for-young-children-with-uncontrolled-asthma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupuytren-contracture-needle-procedure-with-corticosteroid-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupuytren-s-contracture-bacterial-collagenase-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dupuytren-s-contracture-comparing-treatment-options</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/durvalumab-after-chemo-and-radiation-for-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/durvalumab-for-limited-stage-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/durvalumab-for-non-surgical-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dystonia-botulinum-toxin-for-arm-tremors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/dzr123-for-advanced-solid-tumors-and-lymphomas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/e-coli-urinary-tract-infection-pivmecillinam-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-alzheimer-s-disease-nio752-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-alzheimer-s-disease-sabirnetug-infusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-alzheimers-disease-ad04-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-abemaciclib-and-giredestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-camizestrant-vs-standard-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-elacestrant-and-ribociclib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-imlunestrant-vs-standard-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-ribociclib-with-endocrine-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-breast-cancer-trastuzumab-deruxtecan-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-onset-alzheimer-s-disease-aln-app-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-rectal-cancer-fare-trial-with-68ga-ga-fapi-46-pet-ct</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-rheumatoid-arthritis-biomarker-study-for-abatacept</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-stage-arthritis-baricitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-stage-breast-cancer-long-term-follow-up-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-stage-colon-cancer-niche-trial-for-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/early-triple-negative-breast-cancer-durvalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ebv-infection-testing-2lebv-r-and-2lxfs-r-for-fatigue</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/echinococcosis-albendazole-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ectopic-pregnancy-mifepristone-and-letrozole-vs-methotrexate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eculizumab-for-hypertensive-emergency-associated-kidney-condition</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efepoetin-alfa-for-anemia-in-chronic-kidney-disease-on-dialysis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efgartigimod-and-emasiprubart-healthy-adult-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efgartigimod-for-children-with-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efgartigimod-for-early-treatment-of-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efgartigimod-ph20-sc-for-children-with-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/efruxifermin-for-non-cirrhotic-nash-mash</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/egfr-mutant-non-small-cell-lung-cancer-bg-60366-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/egfr-mutated-lung-cancer-eris-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/egl-001-for-advanced-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/egl-003-for-autoimmune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ela026-for-secondary-hemophagocytic-lymphohistiocytosis-shlh</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/elderly-primary-cns-lymphoma-high-dose-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/elderly-surgery-comparing-anesthesia-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/elgn-2112-for-intestinal-malabsorption-in-preterm-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/emergency-pain-relief-sublingual-sufentanil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/emergency-tracheal-intubation-new-optimization-strategy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/emicizumab-dosing-in-congenital-hemophilia-a-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/end-of-life-care-midazolam-and-morphine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/end-stage-kidney-disease-csl300-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/end-stage-renal-disease-rivaroxaban-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-durvalumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-nepa-for-nausea-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-new-treatment-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-new-treatment-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-olaparib-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-rainbo-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-cancer-sacituzumab-tirumotecan-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endometrial-stromal-sarcoma-aromatase-inhibitor-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endoscopic-sleeve-gastroplasty-impact-of-proton-pump-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/endurance-performance-pseudoephedrine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/enpp1-deficiency-inz-701-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ensifentrine-for-non-cystic-fibrosis-bronchiectasis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/enterococcus-faecalis-endocarditis-continuous-infusion-antibiotics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-asthma-benralizumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-esophagitis-bp1-7881-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-esophagitis-budesonide-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-esophagitis-ep-104gi-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-gastritis-dupilumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-granulomatosis-with-polyangiitis-mepolizumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eosinophilic-granulomatosis-with-polyangiitis-ns-229-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epcoritamab-for-relapsed-large-b-cell-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epcoritamab-for-relapsed-primary-cns-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epcoritamab-for-relapsed-refractory-chronic-lymphocytic-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ependymoma-treatment-siop-ependymoma-ii-program</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epi-his-trial-exploring-new-treatment-options</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epidermolysis-bullosa-abcb5-stem-cell-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epidermolysis-bullosa-simplex-apremilast-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epidermolysis-bullosa-simplex-diacerein-1-ointment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epiflux-investigating-a-new-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epilepsy-long-term-study-of-xen1101</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/episodic-migraine-atogepant-for-kids-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/episodic-migraine-medi0618-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/episodic-migraine-xeomin-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epithelial-ovarian-cancer-letrozole-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epithelial-ovarian-cancer-sentinel-node-detection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epithelioid-malignant-pleural-mesothelioma-atezolizumab-and-wt1-dc-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eplontersen-for-transthyretin-mediated-amyloid-cardiomyopathy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epo-trauma-epoetin-alfa-for-critically-ill-trauma-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/epstein-barr-virus-diseases-tabelecleucel-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eptinezumab-for-migraines-in-children-and-adolescents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/eptinezumab-for-pediatric-migraine-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erase-ph-copd-new-treatment-for-copd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erectile-dysfunction-botulinum-toxin-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erectile-rehabilitation-with-sildenafil-after-rectal-cancer-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erlotinib-distribution-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erosive-esophagitis-linaprazan-glurate-vs-lansoprazole</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erosive-esophagitis-nexium-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erosive-esophagitis-oral-pantoprazole-for-kids-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/erythema-migrans-saccharomyces-boulardii-probiotic-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esketamine-for-schizophrenia-symptoms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-achalasia-ppi-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-adenocarcinoma-metformin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-adenocarcinoma-the-presto-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-detection-fluorescent-tracers-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-ifinatamab-deruxtecan-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-ifinatamab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-preventing-infections-after-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-tislelizumab-for-elderly-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-trastuzumab-and-pertuzumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-cancer-treatment-the-needs-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/esophageal-strictures-budesonide-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/essential-tremor-bp1-4979-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/etrasimod-for-adolescents-with-ulcerative-colitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/etrasimod-in-breastfeeding-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/etripamil-nasal-spray-for-pediatric-heart-condition</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/evaluating-safety-of-cor-1389</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/everolimus-for-bone-and-muscle-health-in-the-elderly</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ewing-s-sarcoma-naxitamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ewing-sarcoma-comparing-chemotherapy-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ewing-sarcoma-dinutuximab-beta-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ewing-sarcoma-regorafenib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/exenatide-for-early-parkinsons-disease-progression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/exercise-and-statin-use-in-advanced-cancer-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extensive-stage-small-cell-lung-cancer-i-dxd-with-atezolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extensive-stage-small-cell-lung-cancer-thor-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/external-cephalic-version-propofol-vs-spinal-analgesia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extra-mammary-paget-s-disease-pagetex-device-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extracranial-malignant-germ-cell-tumors-carboplatin-vs-cisplatin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extrahepatic-cholangiocarcinoma-durvalumab-with-radiofrequency-ablation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/extrapulmonary-small-cell-carcinoma-durvalumab-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fabry-disease-migalastat-for-kidney-impairment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fabry-disease-prx-102-for-children-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fabry-disease-venglustat-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/facial-lines-ipn10200-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/familial-chylomicronemia-syndrome-akcea-apociii-lrx-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/familial-hypercholesterolemia-inclisiran-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/familial-hypercholesterolemia-inclisiran-vs-alirocumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/familial-mediterranean-fever-on-demand-anakinra-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/familial-polycythemia-new-drug-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fanconi-anaemia-gene-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fanconi-anemia-afatinib-for-advanced-squamous-cell-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fanconi-anemia-long-term-study-of-rp-l102-infusion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fapi-pet-imaging-for-pleural-mesothelioma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fast-acting-insulins-and-their-post-meal-effects-in-type-1-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fasudil-for-early-alzheimer-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/favipiravir-high-dose-tolerance-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fb301-first-in-human-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/febrile-neutropenia-safe-study-on-short-antibiotic-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-incontinence-botulinum-toxin-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-incontinence-icef15-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiome-transplantation-for-decompensated-cirrhosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiota-transfer-for-diabetes-control-after-bariatric-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiota-transplantation-for-axial-spondyloarthritis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiota-transplantation-for-blood-cancer-stem-cell-transplant-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiota-transplantation-for-crohns-disease-after-anti-tnf-withdrawal</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fecal-microbiota-transplantation-kf2022-1-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/felzartamab-for-kidney-transplant-recipients-with-late-antibody-mediated-rejection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/felzartamab-for-late-antibody-mediated-rejection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fertility-preservation-for-breast-cancer-tamoxifen-and-ovarian-stimulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fertility-study-metformin-for-women-post-thyroid-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fertility-treatment-natural-progesterone-vs-gnrh-antagonists</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fertility-treatment-progesterone-support-in-iui</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fertility-treatments-comparing-ovarian-stimulation-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fetal-and-neonatal-alloimmune-thrombocytopenia-nipocalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrodysplasia-ossificans-progressiva-fidrisertib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrodysplasia-ossificans-progressiva-incb000928-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrolamellar-hepatocellular-carcinoma-dnajb1-prkaca-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrotic-interstitial-lung-disease-morphine-for-breathlessness</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrotic-lung-disease-inhaled-treprostinil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fibrotic-lung-disease-wharton-s-jelly-stem-cells</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/filgotinib-for-rare-immune-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/filgrastim-for-severe-bullous-drug-eruptions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/first-in-human-trial-of-ox118</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fish-oil-for-recovery-in-high-risk-heart-surgery-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/flu-vaccine-study-for-adults-65-and-older</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/flu-vaccine-study-laiv-in-young-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fludarabine-in-stem-cell-transplantation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fluid-management-in-critically-ill-adults-crusaders-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fluid-overload-in-icu-furosemide-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fluorescence-imaging-in-crohns-disease-and-psoriasis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/focal-onset-seizures-extended-release-levetiracetam-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/focal-onset-seizures-study-of-xen1101</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/focal-segmental-glomerulosclerosis-dmx-200-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/focal-seizures-prax-628-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-epcoritamab-with-rituximab-and-lenalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-golcadomide-with-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-mosunetuzumab-and-lenalidomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-mosunetuzumab-and-zanubrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-odronextamab-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-radiotherapy-with-obinutuzumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-tazemetostat-with-lenalidomide-and-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/follicular-lymphoma-tisagenlecleucel-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fore-pain-trial-pain-relief-options-for-trauma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fosfomycin-new-extended-infusion-method</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fosigotifator-for-vanishing-white-matter-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fragile-x-syndrome-long-term-study-of-zyn002-gel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fremanezumab-for-pain-in-complex-regional-pain-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frexalimab-for-nonrelapsing-secondary-progressive-multiple-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/friedreich-ataxia-vatiquinone-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fronto-temporal-dementia-ly3884963-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frontotemporal-dementia-avb-101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frontotemporal-dementia-dnl593-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frontotemporal-dementia-pbft02-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frozen-embryo-transfer-the-role-of-corpus-luteum</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/frozen-shoulder-treatment-corticosteroid-injection-with-nerve-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ft751-safety-and-tolerability-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/functional-dyspepsia-rikkunshito-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/fungal-nail-infection-mob015b-solution-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/futibatinib-safety-study-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ga2-sporozoites-with-adjuvants-immune-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gabapentin-for-nerve-pain-in-the-leg</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrectomy-pancreatic-enzyme-supplementation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-bypass-surgery-tranexamic-acid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-dostarlimab-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-hlx22-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-intraperitoneal-irinotecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-ip-paclitaxel-and-systemic-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-new-drug-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-personalized-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-pre-operative-treatment-with-capecitabine-and-atezolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-treatment-gastrichip-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastric-cancer-zolbetuximab-with-pembrolizumab-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastro-enteropancreatic-neuroendocrine-tumors-ryz101-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroenteropancreatic-and-thoracic-neuroendocrine-tumors-cabozantinib-and-lanreotide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroenteropancreatic-neuroendocrine-tumors-new-liver-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroesophageal-adenocarcinoma-mk-2870-with-pembrolizumab-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroesophageal-and-pancreatic-cancer-new-imaging-technique</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroesophageal-cancer-sertraline-with-immunochemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroesophageal-reflux-disease-in-infants-diet-vs-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-cancer-aerosolized-nanoliposomal-irinotecan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-cancers-mk-2870-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-cancers-patritumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-stromal-tumor-adjuvant-imatinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-stromal-tumor-ripretinib-vs-sunitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-stromal-tumors-idrx-42-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-stromal-tumors-imatinib-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-stromal-tumors-imatinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-tolerability-tegomil-vs-dimethyl-fumarate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastrointestinal-tumors-oncogreen-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroparesis-naronapride-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gastroparesis-tradipitant-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gd2-positive-solid-cancers-gd2il18cart-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gen1047-for-solid-tumors-first-in-human-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gene-therapy-for-central-nervous-system-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gene-therapy-for-crigler-najjar-syndrome-gnt0003</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gene-therapy-for-hearing-loss-aavanc80-hotof</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gene-therapy-for-vision-loss-spvn20-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-anxiety-disorder-iti-1284-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-anxiety-disorder-mm120-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-descartes-08-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-dnth103-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-efgartigimod-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-imvt-1402-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-iptacopan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-ravulizumab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-myasthenia-gravis-telitacicept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/generalized-periodontitis-valaciclovir-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/genetically-modified-t-cells-for-ror1-positive-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/genital-herpes-im-250-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/genitourinary-syndrome-of-menopause-cellular-matrix-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gentamicin-injection-for-cat-scratch-disease-lymphadenitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/geographic-atrophy-jnj-81201887-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/geographic-atrophy-pozelimab-and-cemdisiran-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/geographic-atrophy-tinlarebant-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gestational-trophoblastic-neoplasias-avelumab-and-methotrexate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ghb-use-disorder-baclofen-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ghf-201-new-drug-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ghrelin-for-acute-ischemic-stroke-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/giant-cell-arteritis-and-polymyalgia-rheumatica-hydrocortisone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/giant-cell-arteritis-and-rheumatoid-arthritis-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/giant-cell-arteritis-etanercept-vs-methotrexate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/giant-cell-arteritis-imaging-study-with-18f-fluor-peg-folate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/giant-cell-arteritis-stopping-tocilizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ginisortamab-for-advanced-pancreatic-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gist-treatment-lenvatinib-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glaucoma-oral-semaglutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glibenclamide-for-high-blood-sugar-in-premature-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-131i-tlx101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-177lu-lu-dota-tate-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-177lu-lu-neob-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-adding-zoledronic-acid-to-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-bevacizumab-with-radiochemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-dendritic-cell-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-dendritic-cell-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-early-intensified-treatment-with-temozolomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-intraoperative-photodynamic-therapy-with-pentalafen-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-l19tnf-and-lomustine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-meclofenamate-with-temozolomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-multiforme-itraconazole-with-radiotherapy-and-temozolomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-multiforme-long-term-safety-of-temferon</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-radiodynamic-therapy-with-5-aminolevulinic-acid</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-radioimmunotherapy-with-lutetium-177</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-treatment-lomustine-and-temozolomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-treatment-lomustine-with-or-without-reirradiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-treatment-olaptesed-pegol-with-radiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioblastoma-treatment-optune-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glioma-treatment-study-temozolomide-and-lomustine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glm101-for-pmm2-cdg-safety-and-effects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glofitamab-for-pediatric-b-cell-non-hodgkin-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glucose-distribution-in-severely-burned-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glucothera-plus-for-children-on-peritoneal-dialysis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glycerol-phenylbutyrate-for-pyruvate-dehydrogenase-deficiency</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/glycopyrronium-for-asthma-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/golcadomide-for-brain-lymphoma-a-phase-2-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gout-treatment-immediate-vs-delayed-febuxostat</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gout-treatment-prednisolone-vs-colchicine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graall2014-clinical-trial-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-anti-lymphocyte-serum-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-corticosteroids-with-ecp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-mc0518-treatment-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-mc0518-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-prevention-cy-met-ric-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graft-versus-host-disease-prevention-in-elderly-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/granulomatosis-with-polyangiitis-new-salvage-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/grass-allergy-vitamin-d-enhanced-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/grass-pollen-allergy-clu-rx-phl-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/grass-pollen-allergy-sublingual-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graves-disease-imvt-1402-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graves-disease-rilzabrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/graves-ophthalmopathy-diclofenac-vs-simvastatin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/group-b-streptococcus-vaccine-gbs-nn-nn2-in-pregnant-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/growth-hormone-and-liver-fat-metabolism-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/growth-hormone-deficiency-lum-201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/grt7040-first-in-human-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gsdia-dtx401-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gsk4418959-for-solid-tumors-a-new-treatment-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gsk5764227-for-advanced-gastrointestinal-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gtx-102-for-children-with-angelman-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gtx-11-safety-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/guselkumab-for-active-psoriatic-arthritis-axial-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/guselkumab-for-children-with-ulcerative-colitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/guselkumab-for-crohn-s-disease-healing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/guselkumab-for-kids-with-inflammatory-conditions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/guselkumab-for-pediatric-crohns-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/gvhd-prevention-in-elderly-aml-mds-patients-thymoglobulin-vs-grafalon</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/h3-k27m-mutant-diffuse-glioma-onc201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/haemophilia-a-efanesoctocog-alfa-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/haemophilia-a-inno8-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hairy-cell-leukemia-vemurafenib-and-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hallux-valgus-surgery-ropivacaine-ankle-block-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hamstring-injury-hyperbaric-oxygen-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hand-osteoarthritis-metformin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-amivantamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-carboplatin-paclitaxel-and-cetuximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-cetuximab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-dostarlimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-ficerafusp-alfa-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-ficlatuzumab-and-cetuximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-inbrx-106-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-nbtxr3-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-new-drug-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-new-imaging-technique</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-new-treatment-approach-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-new-treatment-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-niraparib-and-dostarlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-nivolumab-and-ipilimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-pembrolizumab-with-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-petosemtamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-petosemtamab-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-shortened-chemotherapy-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-tb0010-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-cancer-vb10-16-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-and-neck-or-liver-cancer-testing-new-drug-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/head-trauma-safety-of-inhaled-isoflurane</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/headache-relief-sphenopalatine-block-for-subarachnoid-hemorrhage</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/healthy-adults-effect-of-high-fat-meal-on-do-2</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/healthy-men-study-of-inno8-dosing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/healthy-volunteers-needed-bi-3000202-interaction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/healthy-volunteers-needed-for-new-autotaxin-inhibitor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/healthy-volunteers-needed-itraconazole-and-bi-3031185-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hearing-loss-in-children-db-oto-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hearing-loss-prevention-sodium-thiosulfate-for-chemotherapy-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-prevention-selatogrel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-recovery-bempedoic-acid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-recovery-dabigatran-vs-vitamin-k-antagonist</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-recovery-ferric-carboxymaltose-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-recovery-milvexian-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-recovery-ziltivekimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-cangrelor-and-bivalirudin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-evolocumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-evolocumab-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-methylprednisolone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-rtp-026-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-the-dan-dapt-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-attack-treatment-timing-of-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-blood-flow-measurement-syn2-pet-imaging</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-disease-azd0780-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-disease-treatment-drug-coated-balloon-vs-drug-eluting-stents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-and-kidney-disease-seneka-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-and-obesity-weight-loss-with-semaglutide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-balcinrenone-dapagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-cdr132l-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-colchicine-and-thiamine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-colchicine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-comparing-spironolactone-and-eplerenone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-empagliflozin-and-dapagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-engineered-heart-tissue-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-finerenone-and-sglt2-inhibitor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-finerenone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-hyperpolarized-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-in-children-vericiguat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-jtt-861-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-optimizing-drug-levels</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-pf-07328948-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-risk-baxdrostat-with-dapagliflozin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-sacubitril-valsartan-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-sertraline-for-anxiety-and-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-stopping-beta-blockers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-stopping-medication-after-cardiac-resynchronization-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-treatment-carvedilol-vs-metoprolol</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-treatment-sacubitril-valsartan-vs-ramipril</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-trimetazidine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-vericiguat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-failure-vicadrostat-and-empagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-function-in-cancer-patients-nivolumab-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-function-study-dobutamine-in-attrwt-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-health-adenosine-dose-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-health-apixaban-vs-warfarin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-health-orticumab-for-inflammation-after-heart-attack</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-health-ticagrelor-with-aspirin-after-cabg</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-health-treatment-for-frequent-pvcs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-inflammation-immunosuppressive-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-patients-reduced-dose-of-prasugrel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-beta-blocker-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-comparing-blood-thinners</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-protamine-administration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-protamine-use-in-aortic-valve-replacement</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-short-vs-long-antiplatelet-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-procedure-single-vs-dual-antiplatelet-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-surgery-buckberg-vs-del-nido-cardioplegia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/heart-transplant-in-children-comparing-custodiol-and-custodiol-n</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematologic-cancers-continued-treatment-with-tafasitamab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematologic-malignancies-gene-modified-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematologic-malignancies-htlp-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematologic-malignancies-mk-1026-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematological-cancers-in-children-new-drug-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hematopoietic-cell-transplantation-comparing-conditioning-regimens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemolytic-uremic-syndrome-inm004-treatment-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemophilia-a-dendritic-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemophilia-a-efanesoctocog-alfa-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemophilia-a-innovative-treatment-approaches-for-patients-with-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemophilia-a-long-term-follow-up-of-bmn-270</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemophilia-b-regv131-lnp1265-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemoptysis-treatment-txa-vs-terlipressin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hemorrhoidal-disease-rafaelo-r-procedure-with-pain-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatitis-b-samba-study-on-antibodies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatitis-b-thervacb-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatoblastoma-and-hepatocarcinoma-personalized-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-cancer-and-lung-cancer-abbv-324-vs-lenvatinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-68ga-psma-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-aln-bcat-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-atezolizumab-bevacizumab-with-bacterial-supplements</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-durvalumab-and-bevacizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-durvalumab-and-tremelimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-durvalumab-and-tremelimumab-with-y-90-sirt</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-ima970a-and-durvalumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-livmoniplimab-and-budigalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-new-vaccine-with-atezolizumab-and-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-nms-01940153e-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hepatocellular-carcinoma-triple-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-altered-cancers-zongertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-breast-cancer-tucatinib-with-oral-etoposide-and-trastuzumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-cancer-treatment-zongertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-cancers-iam1363-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-expressing-cancers-vir-5818-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-expressing-ovarian-cancer-trastuzumab-deruxtecan-with-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-expressing-tumors-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-low-breast-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-low-metastatic-breast-cancer-db-1303-vs-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-metastatic-colorectal-cancer-tucatinib-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-mutated-solid-tumors-sevabertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-negative-breast-cancer-pembrolizumab-and-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-biliary-tract-cancer-gemcis-with-trastuzumab-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-breast-cancer-glsi-100-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-breast-cancer-new-treatment-without-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-breast-cancer-trastuzumab-and-pertuzumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-breast-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-breast-cancer-zanidatamab-vs-trastuzumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-early-breast-cancer-inavolisib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-esophageal-cancer-heres-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-gastric-cancer-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-gastric-cancer-rilvegostomig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-gastric-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-glioblastoma-nk-92-5-28-z-cells-and-ezabenlimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-metastatic-breast-cancer-177lu-lu-aby-271-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-metastatic-breast-cancer-es2b-c001-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-metastatic-cancer-trastuzumab-emtansine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-non-small-cell-lung-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-oligo-metastatic-breast-cancer-t-dxd-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-positive-solid-tumors-disitamab-vedotin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-status-in-solid-tumors-68ga-ga-aby-025-pet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her2-targeting-imaging-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her3-dxd-for-advanced-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/her3-targeted-imaging-with-patritumab-deruxtecan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-bw-20805-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-deucrictibant-extended-release-tablet</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-deucrictibant-tablet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-navenibart-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-octa-c1-inh-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-angioedema-pha-022121-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-haemochromatosis-nnc0614-0001-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-ichthyosis-injectable-gentamicin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hereditary-transthyretin-mediated-amyloid-polyneuropathy-ion-682884-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hernia-repair-comparing-pain-relief-techniques</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/herpes-zoster-vaccine-for-immunocompromised-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/herpes-zoster-vaccine-impact-on-patients-with-inflammatory-rheumatic-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-avtx-009-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-bimekizumab-for-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-brensocatib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-ic0624-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-lutikizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-new-antibiotic-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-remibrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-ruxolitinib-cream-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-secukinumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-sonelokimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-sonelokimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-tibulizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hidradenitis-suppurativa-upadacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-bad-cholesterol-azd0780-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-blood-pressure-irbesartan-and-amlodipine-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-blood-pressure-metyrapone-for-adrenal-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-cardiovascular-risk-rosuvastatin-vs-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-dose-influenza-vaccine-for-adults-60-and-older</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-grade-glioma-abemaciclib-with-temozolomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-grade-glioma-in-children-larotrectinib-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-grade-glioma-in-children-rapamycin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-grade-glioma-new-imaging-technique</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-grade-soft-tissue-sarcoma-ifosfamide-and-doxorubicin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-aggressive-b-cell-lymphomas-r-hyper-cvad-r-ma-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-breast-cancer-personalized-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-essential-thrombocythaemia-stp938-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-medulloblastoma-new-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-melanoma-neoadjuvant-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-myelodysplastic-syndromes-stem-cell-transplantation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-neuroblastoma-dinutuximab-beta-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-neuroblastoma-naxitamab-and-gm-csf-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-polycythemia-vera-ruxolitinib-vs-standard-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-prostate-cancer-thunder-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-retroperitoneal-sarcoma-chemotherapy-before-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/high-risk-thyroid-cancer-neoadjuvant-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/higher-risk-myelodysplastic-syndrome-lisaftoclax-with-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hip-replacement-antibiotic-impregnated-bone-graft-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hip-replacement-pain-management-nefopam-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hip-replacement-peng-block-vs-lumbar-plexus-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hip-replacement-surgery-shorter-blood-thinner-duration</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/histiocytosis-fludeoxyglucose-18f-fdg-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/histiocytosis-in-children-trametinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-control-genetic-and-immune-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-infection-art-with-long-acting-antibodies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-prevention-mk-8527-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-reservoir-study-itaco-and-itaco-ati</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-treatment-bictegravir-lenacapavir-for-kids-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-treatment-high-dose-antiretroviral-drugs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-1-treatment-long-acting-cabotegravir-and-rilpivirine-for-older-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-and-hbv-co-infection-antiviral-treatment-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-and-hepatitis-b-bepirovirsen-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-and-liver-health-doravirine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-control-pomalidomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-prevention-long-acting-injectable-cabotegravir-vs-daily-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-prevention-taf-ftc-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-research-topiramate-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-combination-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-comparing-dor-3tc-and-dtg-3tc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-comparison-doravirine-vs-dolutegravir</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-doravirine-tenofovir-lamivudine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-imc-m113v-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-mk-4646-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-new-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hiv-treatment-venetoclax-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hmb-001-for-glanzmann-thrombasthenia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-lymphoma-a2vd-vs-abvd-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-lymphoma-chemotherapy-alone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-lymphoma-ruxolitinib-with-brentuximab-or-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-lymphoma-tislelizumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-lymphoma-tislelizumab-with-gemcitabine-and-cisplatin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-s-lymphoma-atezolizumab-and-begev-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hodgkin-s-lymphoma-nivolumab-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hormonal-contraceptives-brain-effects-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hormonal-treatment-for-adolescents-with-gender-dysphoria</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hot-flashes-after-breast-cancer-oxybutynin-vs-venlafaxine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-16-flubhpve6e7-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-infections-2lpapi-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-negative-head-and-neck-cancer-parp-inhibitor-and-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-vaccination-after-cervical-lesion-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-vaccination-timing-after-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-vaccine-effectiveness-study-for-young-men</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-vaccine-panhpvax</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv-vaccine-study-for-women-with-hpv-16-18</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hpv16-related-throat-cancer-flubhpve6e7-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hunter-syndrome-long-term-safety-of-idursulfase-it-and-elaprase-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/huntington-s-disease-innovative-biomarker-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroceles-and-spermatoceles-comparing-sclerotherapy-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydrochlorothiazide-for-polycystic-kidney-disease-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydrocortisone-absorption-oral-vs-oral-mucosa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydrocortisone-treatment-in-pancreatoduodenectomy-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroxychloroquine-for-early-systemic-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroxychloroquine-for-extra-pulmonary-sarcoidosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroxychloroquine-for-mastocytosis-symptoms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroxychloroquine-for-pregnancy-outcomes-in-women-with-antiphospholipid-antibodies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hydroxychloroquine-for-recurrent-pregnancy-loss</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hyperbaric-oxygen-therapy-for-sudden-hearing-loss</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypereosinophilic-syndrome-depemokimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hyperkalaemia-in-children-szc-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertension-and-obesity-orforglipron-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertension-in-chronic-kidney-disease-diuretic-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertonic-lactate-after-cardiac-arrest-the-latte-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertrophic-cardiomyopathy-aficamten-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertrophic-cardiomyopathy-bisoprolol-vs-verapamil</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypertrophic-cardiomyopathy-sotagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypochondroplasia-infigratinib-for-growth</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypochondroplasia-vosoritide-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypogammaglobulinemia-xembify-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hyponatremia-empagliflozin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypophosphatasia-alxn1850-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypophosphatasia-in-children-alxn1850-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hypotension-treatment-early-vasopressor-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hysterectomy-pain-relief-local-anesthetic-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/hystindo-study-indocyanine-green-in-laparoscopic-hysterectomy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ibrutinib-for-autoimmune-hemolytic-anemia-in-cll-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/icotrokinra-understanding-its-effects-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idh1-idh2-mutant-glioma-vorasidenib-with-temozolomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-bile-acid-diarrhea-colesevelam-hydrochloride-tablet</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-hypersomnia-alks-2680-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-hypersomnia-melatonin-and-light-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-hypersomnia-tak-360-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-infertility-metformin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-inflammatory-myopathies-upadacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-inflammatory-myopathy-efgartigimod-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-membranous-nephropathy-ap1189-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-pulmonary-fibrosis-axatilimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-pulmonary-fibrosis-buloxibutid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-pulmonary-fibrosis-cal101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-pulmonary-fibrosis-cmr316-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idiopathic-retroperitoneal-fibrosis-early-steroid-discontinuation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/idor-1134-2831-vaccine-healthy-participants-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ifinatamab-deruxtecan-for-metastatic-prostate-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iga-nephropathy-atacicept-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iga-nephropathy-felzartamab-infusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iga-nephropathy-hydroxychloroquine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/igg4-related-disease-abatacept-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/igg4-related-disease-obexelimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/igm-monoclonal-gammopathy-zanubrutinib-and-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ikervis-for-atopic-keratoconjunctivitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iks03-for-advanced-b-cell-non-hodgkin-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/il12-l19l19-treatment-safety-and-early-efficacy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ileal-crohns-disease-azd7798-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iluvien-r-eye-implant-for-children-with-uveitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/imaging-a-synuclein-in-the-brain-18f-aci-15916</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/imc-f106c-for-advanced-prame-positive-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/imlifidase-for-severe-anca-associated-vasculitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-activation-flamod-aerosol-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-related-rheumatological-events-in-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-response-study-posdinemab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-avatrombopag-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-dexamethasone-vs-ivig</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-new-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-nvg-2089-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-pirtobrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immune-thrombocytopenia-rituximab-with-belimumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immuno-oct-imaging-safety-and-feasibility-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunoglobulin-a-nephropathy-povetacicept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunoglobulin-a-nephropathy-ravulizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunoglobulin-a-nephropathy-sibeprenlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunological-diseases-ray121-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunopet-imaging-in-solid-cancers-89zr-dfo-regn5054</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-advanced-cancer-standard-vs-reduced-dose</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-cutaneous-squamous-cell-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-early-dmmr-rectal-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-high-risk-oral-disorders-aphrodite-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-metastatic-colorectal-and-prostate-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/immunotherapy-for-msi-dmmr-tumors-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/improving-ovarian-reserve-rhlh-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/improving-sleep-and-mood-in-postmenopausal-women-dhea-and-melatonin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inbrx-109-for-advanced-solid-tumors-including-sarcomas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inclisiran-for-children-with-high-cholesterol</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inclusion-body-myositis-abc008-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inclusion-body-myositis-ruxolitinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/individualized-immunotherapy-for-early-stage-hodgkin-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/indocyanine-green-in-gynecological-cancer-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/indolent-non-hodgkin-s-lymphoma-eo2463-cancer-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inebilizumab-for-children-with-neuromyelitis-optica-spectrum-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infant-immunity-to-whooping-cough-maternal-vaccination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infantile-onset-pompe-disease-cipaglucosidase-alfa-miglustat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infantile-spasms-vigabatrin-for-high-risk-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infection-prevention-in-joint-replacement-prevent-it-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infectious-endocarditis-shorter-antibiotic-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infectious-pulmonary-endotheliopathy-iloprost-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infective-endocarditis-oral-vs-parenteral-antibiotics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-bowel-disease-adalimumab-680lt-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-bowel-disease-and-rheumatoid-arthritis-adalimumab-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-bowel-disease-risankizumab-800cw-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-bowel-disease-vedolizumab-dose-reduction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-disorders-new-imaging-tracer-18f-alf-fapi-74</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inflammatory-rheumatic-diseases-jak-inhibitor-dose-reduction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/infliximab-for-non-crohn-anal-fistulas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccination-antibody-responses-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-after-heart-attack-eliminate-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-study-for-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-study-for-adults-aged-65-79</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-study-for-hematological-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-study-ovx836</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/influenza-vaccine-study-seqirus-h5n8</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inhaled-levosimendan-understanding-how-it-works</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inhaled-molgramostim-for-pediatric-autoimmune-pulmonary-alveolar-proteinosis-apap</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inhaled-sevoflurane-for-sedation-in-critically-ill-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inhaled-therapy-for-high-risk-thoracic-surgery-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/innovative-cell-therapy-for-autoimmune-xerostomia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inotuzumab-ozogamicin-for-pediatric-acute-lymphoblastic-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/insomnia-in-adolescents-melatonin-vs-quetiapine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/insomnia-in-psychiatric-patients-melatonin-vs-quetiapine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/insulin-eye-drops-for-persistent-corneal-epithelial-defects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intensive-care-incept-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/interstitial-lung-disease-rituximab-and-mycophenolate-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intestinal-failure-associated-liver-disease-nst-6179-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intra-hepatic-cholangiocarcinoma-new-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intracerebral-hemorrhage-anticoagulation-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intrahepatic-cholangiocarcinoma-pump-iv-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intranasal-covid-19-vaccine-lvt-001</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intranasal-lysine-aspirin-for-respiratory-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intrathecal-baclofen-for-spinal-cord-injury-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/intravenous-iron-for-mobility-after-hip-fracture-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/invasive-aspergillosis-olorofim-vs-ambisome-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/investigational-drug-mp-101-for-als-and-alzheimer-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/inz-701-for-enpp1-and-abcc6-deficiency</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iptacopan-for-pediatric-patients-with-pnh</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iron-deficiency-anemia-in-children-ferumoxytol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/iron-supplement-for-better-recovery-after-major-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/irritable-bowel-syndrome-ebastine-vs-mebeverine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/irritable-bowel-syndrome-gsl-01-001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/irritable-bowel-syndrome-myrrhinil-intest-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/irritable-bowel-syndrome-saccharomyces-boulardii-cncm-i-745</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/irritable-bowel-syndrome-symbioflor-r-2-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/isatuximab-for-relapsed-refractory-t-cell-acute-lymphoblastic-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ischemic-stroke-doac-intravenous-thrombolysis-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ischemic-stroke-thrombolytic-therapy-with-rtpa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/isolated-mma-long-term-study-of-mrna-3705</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/itacitinib-continued-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ittp-treatment-tak-755-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ivf-icsi-low-dose-hcg-priming-for-women-with-diminished-ovarian-reserve</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ivf-icsi-optimizing-recombinant-fsh-dosing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ivf-luteal-phase-support-gnrh-agonist-vs-hcg</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ivf-success-exercise-and-mediterranean-diet-vs-aspirin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ivosidenib-for-acute-myeloid-leukemia-after-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/jak1-inhibitor-for-large-inflammatory-liver-adenomas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/jjp-1212-new-immune-response-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/jnj-90106848-safety-and-body-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-baricitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-bimekizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-biosimilar-vs-original-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-early-drug-withdrawal-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-filgotinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-move-jia-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-idiopathic-arthritis-upadacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-psoriatic-arthritis-deucravacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/juvenile-psoriatic-arthritis-risankizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kamada-aat-for-inhalation-in-alpha-1-antitrypsin-deficiency</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/karonudib-for-blood-cancers-phase-1-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kcnt1-related-epilepsy-s230815-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ketamine-for-depression-and-alcohol-use-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ketamine-for-depression-brain-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ketamine-for-reducing-opioid-use-in-severe-trauma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ketamine-for-treating-disorders-of-consciousness-after-coma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ketamine-therapy-for-obsessive-compulsive-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-biopsy-desmopressin-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-cancer-new-combination-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-cancer-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-cancer-savolitinib-plus-durvalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-disease-ale-f02-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-disease-frexalimab-brivekimig-and-rilzabrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-disease-iptacopan-lnp023-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-disease-vx-147-study-for-apol1-variants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-function-non-radioactive-measurement-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-function-vonafexor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-after-liver-transplant-human-albumin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-after-transplant-dapagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-bia-28-6156-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-co2-injection-in-vascular-procedures</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-in-type-2-diabetes-empagliflozin-and-finerenone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-health-sglt2-inhibitor-for-prediabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-protection-cilastatin-vs-thiosulfate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-protection-semaglutide-and-finerenone-in-ckd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-stones-furosemide-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-alkaline-phosphatase-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-autologous-tolerogenic-dendritic-cells</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-belatacept-vs-anticalcineurins</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-belatacept-vs-calcineurin-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-belatacept-vs-traditional-immunosuppressants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-bivv020-for-rejection-prevention-and-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-comparing-ratg-and-basiliximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-eight-treg-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-imlifidase-for-highly-sensitized-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-in-children-prolonged-release-tacrolimus-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-ivig-for-bkv-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-mannitol-vs-normal-saline</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-optimal-dose-of-grafalon-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-ravulizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-reduced-immunosuppression-for-older-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-regulatory-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-rejection-efgartigimod-ph20-sc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-rejection-everolimus-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-rejection-intercept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-rituximab-for-ebv-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplant-sglt2-inhibitor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kidney-transplantation-donor-modified-immune-cells</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/kin-2787-new-oral-drug-for-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/klinefelter-syndrome-testosterone-treatment-in-puberty</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-cartilage-damage-uc-msc-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-cartilage-defects-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-bovine-vs-marine-chondroitin-sulfate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-diclofenac-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-genicular-arteries-embolization-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-intra-articular-clodronate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-kbp-336-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-study-of-4p004-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-osteoarthritis-syn321-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-replacement-surgery-local-anesthetic-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-surgery-pain-relief-nefopam-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-surgery-pain-relief-oral-vs-iv-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/knee-surgery-testing-srsd107-for-blood-clot-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ko-2806-for-advanced-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/labor-induction-outpatient-vs-inpatient-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/labor-induction-oxytocin-vs-prostaglandins</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lactose-intolerance-diagnosis-lactest-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lactose-intolerance-gaxilose-oral-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lanreotide-and-metformin-for-advanced-carcinoids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/large-cell-neuroendocrine-carcinomas-durvalumab-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/large-incisional-hernia-botulinum-toxin-a-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/laryngeal-cancer-elos-study-on-new-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/late-onset-pompe-disease-cipaglucosidase-alfa-and-miglustat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/late-onset-pompe-disease-spk-3006-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/late-renal-graft-failure-immunosuppression-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lb-208-for-relapsed-solid-tumors-and-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/learning-dynamics-atomoxetine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leber-congenital-amaurosis-sepofarsen-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leiomyosarcoma-trabectedin-vs-gemcitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lennox-gastaut-syndrome-carisbamate-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leriglitazone-drug-interaction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leucettinib-21-safety-and-effects-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leukemia-and-lymphoma-dasatinib-and-venetoclax-study-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leukemia-and-lymphoma-ruxolitinib-and-venetoclax-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leukemia-treatment-ponatinib-vs-imatinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/leukemia-venetoclax-with-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/levosimendan-for-faster-recovery-from-ventilation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/levosimendan-for-heart-support-during-ecmo-weaning</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/levosimendan-therapy-for-low-ejection-fraction-takotsubo-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/libra-lithium-for-cognitive-protection-after-brain-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lichen-simplex-chronicus-dupilumab-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/light-chain-amyloidosis-etentamig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/limb-girdle-muscular-dystrophy-2e-r4-srp-9003-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/limited-stage-small-cell-lung-cancer-tarlatamab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/linaprazan-glurate-interaction-with-antibiotic</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/linvoseltamab-for-relapsed-or-refractory-al-amyloidosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liraglutide-effects-on-digestion-and-hunger</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cancer-fecal-microbiota-transfer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cancer-hyperpolarized-pyruvate-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cancer-immunotherapy-and-radioactive-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cancer-tislelizumab-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cirrhosis-rtx001-macrophage-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-cirrhosis-stopping-proton-pump-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-fibrosis-assessment-68ga-fapi-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-health-lepodisiran-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-problems-study-of-vimseltinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-surgery-blood-clot-prevention-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-surgery-octreotide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-transplant-low-dose-arginine-vasopressin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-transplant-qel-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-transplant-regulatory-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-transplant-single-vs-twice-daily-immunosuppressive-doses</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/liver-tumors-indocyanine-green-for-better-detection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lobular-breast-cancer-capivasertib-and-fulvestrant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/localized-ocular-melanoma-ide196-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/localized-prostate-cancer-darolutamide-and-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-nsclc-alectinib-vs-durvalumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-nsclc-new-chemoradiotherapy-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-rectal-cancer-capecitabine-and-temozolomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-rectal-cancer-dostarlimab-and-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-rectal-cancer-folfox-before-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-rectal-cancer-neoaspmet-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-advanced-rectal-cancer-tailored-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/locally-recurrent-rectal-cancer-induction-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-covid-fibroblast-activity-study-with-68ga-fapi-pet-ct</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-follow-up-for-gene-modified-t-cell-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-follow-up-of-adoptive-cell-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-follow-up-of-car-t-cell-therapy-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-of-genetically-modified-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-of-miltenyi-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-study-for-ciltacabtagene-autoleucel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-study-of-dabrafenib-and-trametinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-study-of-gd2il18cart-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-study-of-ntla-2001</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-safety-study-of-ongoing-treatment-with-study-drugs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-study-of-delandistrogene-moxeparvovec-srp-9001</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-study-of-galapagos-car-t-cell-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/long-term-study-on-gene-modified-cell-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/low-back-pain-prgf-endoret-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/low-grade-gliomas-18f-fdopa-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/low-grade-upper-tract-urothelial-cancer-ugn-104-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/low-ovarian-reserve-factor-rich-plasma-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lower-limb-nonunion-nvd-003-implant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lower-limb-trauma-rivaroxaban-vs-heparin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lower-respiratory-infections-acyclovir-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lower-risk-mds-luspatercept-and-epo-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lph-5-first-in-man-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lsd-levels-in-the-brain-neuroimaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lsta1-for-newly-diagnosed-glioblastoma-multiforme</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lumbar-spinal-surgery-erector-spinae-plane-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-abp-234-vs-keytruda</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-adagrasib-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-avutometinib-and-sotorasib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-bms-986507-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-chemoimmunotherapy-with-mek-inhibitor</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-durvalumab-and-domvanalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-enhanced-skin-care-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-iph5201-and-durvalumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-jnj-90301900-with-chemoradiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-nivolumab-with-ipilimumab-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-pembrolizumab-and-lenvatinib-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-pembrolizumab-maintenance-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-repotrectinib-for-elderly-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-rmc-6236-vs-docetaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-sacituzumab-and-zimberelimab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-selpercatinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-adagrasib-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-chemotherapy-atezolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-comparison-atezolizumab-vs-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-ct-p51-vs-keytruda</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-divarasib-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-dzd9008-vs-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-entrectinib-vs-crizotinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-immunotherapy-and-radiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-livmoniplimab-and-budigalimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-mk-2870-vs-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-mk-2870-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-nivolumab-relatlimab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-rilvegostomig-vs-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-telisotuzumab-adizutecan-with-osimertinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-treatment-telisotuzumab-vedotin-vs-docetaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-v940-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-zipalertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-cancer-zipalertinib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-fibrosis-env-101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-fibrosis-in-systemic-rheumatic-diseases-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-fibrosis-nerandomilast-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-health-avalyn-inhaled-antifibrotic-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-surgery-oxygen-delivery-techniques</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-transplant-rejection-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lung-transplantation-heparin-free-heart-lung-support</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-in-children-anifrolumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-nephritis-ianalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-nephritis-kyv-101-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-nephritis-lnp023-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-nephritis-msv-allo-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-nephritis-obinutuzumab-for-adolescents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lupus-treatment-biib059-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/luspatercept-for-anemia-in-lower-risk-mds-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lutetium-lu-177-edotreotide-for-pediatric-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ly3537031-for-liver-function-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ly4057996-a-study-in-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lyell-syndrome-mesenchymal-stromal-cells-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoblastic-lymphoma-new-treatment-protocol-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoma-comparing-pneumococcal-vaccines</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoma-treatment-loncastuximab-tesirine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoma-treatment-mk-3475a-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoma-treatment-stp938</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/lymphoma-treatment-study-zanubrutinib-vs-lenalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/m9466-for-advanced-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/macitentan-dosing-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/macular-telangiectasia-type-1-aflibercept-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depression-samyr-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depression-samyr-r-tablet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-cyb003-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-ketamine-and-ect-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-liposom-forte-with-citalopram</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-lumateperone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-minocycline-vs-celecoxib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-nbi-1065845-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-new-treatment-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/major-depressive-disorder-nmra-335140-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/malaria-prevention-atovaquone-proguanil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/malaria-treatment-ine963-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/malignant-pleural-effusion-pressurized-aerosol-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/malignant-pleural-mesothelioma-innovative-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/malignant-solid-tumors-gen1057-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/managing-anxiety-in-gynecological-surgery-hypnosis-vs-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/managing-high-potassium-lokelma-for-chronic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-acalabrutinib-with-r-chop</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-glofitamab-with-venetoclax-and-zanubrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-ibrutinib-and-venetoclax-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-kte-x19-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-loncastuximab-tesirine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-pirtobrutinib-and-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-sonrotoclax-plus-zanubrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-venetoclax-with-ibrutinib-and-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mantle-cell-lymphoma-zanubrutinib-with-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/marfan-syndrome-valsartan-for-aortic-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/marginal-zone-lymphoma-mosunetuzumab-lenalidomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/maridebart-cafraglutide-for-heart-failure-and-obesity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/marstacimab-for-pediatric-hemophilia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/marstacimab-for-severe-hemophilia-a-and-b</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mb-cart19-1-for-refractory-systemic-lupus-erythematosus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mb-cart2019-1-therapy-for-pediatric-b-cell-neoplasms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mdma-assisted-therapy-for-treatment-resistant-ptsd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mds-and-aml-venetoclax-with-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mds-and-cmml-pxs-5505-with-5-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mechanical-heart-valves-lower-inr-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mecp2-duplication-syndrome-ion440-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/medical-cannabis-aerosol-for-diabetic-peripheral-neuropathic-pain</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/medication-related-osteonecrosis-of-the-jaw-pento-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/medulloblastoma-treatment-memmat-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-68ga-ga-fapi-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-breast-cancer-and-head-neck-cancer-contrast-enhanced-ultrasound-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-direct-tumor-treatment-with-microdosing</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-ipilimumab-and-nivolumab-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-nsclc-and-cervical-cancer-anv419-vs-high-dose-il-2</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-abp-206-vs-opdivo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-comparing-immune-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-comparing-pembrolizumab-formulations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-daromun-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-fianlimab-and-cemiplimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-ltx-315-and-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-nivolumab-relatlimab-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-nivolumab-with-isolated-limb-perfusion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-pembrolizumab-with-new-agents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-short-vs-long-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-tilt-123-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-treatment-vemurafenib-cobimetinib-and-atezolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melanoma-with-brain-metastases-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melas-testing-zagociguat</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/melatonin-for-chronic-back-pain</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/membranous-nephropathy-dapagliflozin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/membranous-nephropathy-personalized-rituximab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/memory-disorders-evaluating-tau-pet-imaging</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/men1703-for-aggressive-b-cell-non-hodgkin-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meniere-s-disease-methylprednisolone-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningioma-treatment-everolimus-and-177lu-dotatate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningiomas-alpelisib-and-trametinib-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningococcal-b-vaccine-for-adults-with-asplenia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningococcal-disease-new-pentavalent-vaccine-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningococcal-vaccine-immune-response-study-in-transgender-and-cisgender-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningococcal-vaccine-study-for-ages-10-20</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meningococcal-vaccine-study-for-infants-and-toddlers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meniscal-loss-spongioflex-r-allografts-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/meniscal-pain-relief-betamethasone-infiltration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/menopausal-women-with-breast-cancer-prasterone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/menstrual-migraine-atogepant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/menstrual-migraine-rimegepant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mependax-axitinib-and-etoposide-for-pediatric-brain-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/merkel-cell-carcinoma-pembrolizumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mesothelioma-talazoparib-maintenance-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metamizole-and-imatinib-interaction-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-177lu-lu-neob-with-capecitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-bgb-43395-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-elacestrant-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-fdg-pet-ct-vs-conventional-ct</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-new-her2-imaging-test</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-next-generation-sequencing-oncochip</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-somatostatin-receptor-pet-scan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-targeted-treatment-based-on-genetic-analysis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-trastuzumab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-breast-cancer-treatment-combinations-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-castration-resistant-prostate-cancer-gedatolisib-and-darolutamide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-and-gastroesophageal-cancer-trifluridine-tipiracil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-arfolitixorin-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-atezolizumab-with-folfoxiri</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-cetuximab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-cetuximab-vs-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-choosing-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-flirt-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-fruquintinib-and-tislelizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-jnj-89402638-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-lb-100-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-new-diagnostic-test-for-treatment-guidance</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-nivolumab-and-ipilimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-personalized-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-post-surgery-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-raxo-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-regorafenib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-s-95005-with-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-targeted-therapies-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-telisotuzumab-adizutecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-tinzaparin-for-blood-clot-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-trifluridine-tipiracil-with-panitumumab-vs-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-colorectal-cancer-valproic-acid-and-standard-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-esophagogastric-cancer-mt-302-with-capox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-fap-positive-solid-tumors-177lu-lu-oncofap-23</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-leiomyosarcoma-lurbinectedin-and-doxorubicin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-lung-cancer-bl-b01d1-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-melanoma-diclofenac-with-pd-1-inhibitor</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-melanoma-early-detection-of-side-effects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-melanoma-v940-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-neuroendocrine-prostate-cancer-targeted-radioligand-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-bms-986504-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-ivonescimab-vs-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-ln-145-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-onc-392-vs-docetaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-pembrolizumab-with-sacituzumab-govitecan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-tedopi-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-visugromab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-volrustomig-plus-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-small-cell-lung-cancer-zimberelimab-and-domvanalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-non-squamous-non-small-cell-lung-cancer-visugromab-and-nivolumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-pancreatic-adenocarcinoma-ttx-030-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-pancreatic-cancer-5-fu-with-naliri-or-nalirinox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-pancreatic-cancer-dostarlimab-with-mfolfirinox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-pancreatic-cancer-valproic-acid-and-simvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-prostate-cancer-jnj-78278343-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-prostate-cancer-probio-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-prostate-cancer-talazoparib-and-enzalutamide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-renal-cell-carcinoma-immunotherapy-and-tumor-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-renal-cell-carcinoma-temferon-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-renal-cell-carcinoma-treatment-comparison-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-squamous-non-small-cell-lung-cancer-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-thyroid-cancer-personalized-131i-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-tumors-atezolizumab-with-sabr</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-urothelial-carcinoma-livmoniplimab-and-budigalimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-uveal-melanoma-ide196-and-crizotinib-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-uveal-melanoma-liver-radiotherapy-with-tebentafusp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metastatic-uveal-melanoma-tebentafusp-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metformin-for-prolonging-pregnancy-in-preterm-preeclampsia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metformin-for-small-abdominal-aortic-aneurysms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metformin-transfer-in-breast-milk-a-study-for-lactating-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/methylmalonic-acidemia-mrna-3705-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/methylphenidate-for-cancer-related-fatigue-in-young-brain-tumor-survivors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/methylphenidate-for-children-with-kbg-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/methylprednisolone-for-infants-with-neuroendocrine-cells-hyperplasia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metoprolol-for-heart-health-in-duchenne-muscular-dystrophy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metreleptin-for-young-children-with-generalized-lipodystrophy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/metycor-study-for-autonomous-cortisol-secretion</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mevrometostat-for-relapsed-refractory-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/microscopic-colitis-sar444336-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/microvillus-inclusion-disease-crofelemer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/midgut-neuroendocrine-tumors-lu177-dotatate-treatment-schedule</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mifepristone-as-a-weekly-contraceptive</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-aura-amiloride-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-prevention-atogepant-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-prevention-comparing-common-medications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-prevention-in-kids-rimegepant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-relief-high-flow-oxygen-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-study-effects-of-cilostazol</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-treatment-in-kids-rimegepant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/migraine-treatment-rimegepant-for-kids-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mild-age-related-hearing-loss-dx243-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mild-male-factor-infertility-pkb171-gel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/milsaperidone-for-major-depressive-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/milvexian-comparing-tablet-formulations-for-kids-and-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mindfulness-training-and-oxytocin-for-stress-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mirikizumab-for-children-with-ulcerative-colitis-or-crohns-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mitapivat-for-children-with-pyruvate-kinase-deficiency</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mitapivat-for-erythrocyte-membranopathies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mitral-valve-surgery-landiolol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mixed-dyslipidaemia-rosuvastatin-and-fenofibrate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mixed-dyslipidemia-rbd5044-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-1084-with-pembrolizumab-for-metastatic-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-2870-vs-chemotherapy-for-advanced-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-4082-a-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-5684-therapies-for-advanced-prostate-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-6050-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mk-7228-a-new-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mmrd-uterine-cancer-pembrolizumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/moderate-acne-oral-isotretinoin-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/moderate-atopic-dermatitis-ruxolitinib-cream-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/moderate-to-severe-asthma-pf-07275315-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mog-antibody-associated-disease-rozanolixizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mog-antibody-disease-azathioprine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mogad-evaluating-satralizumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/momelotinib-for-anemia-in-low-risk-myelodysplastic-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/monalizumab-for-acute-myeloid-leukemia-and-myelodysplastic-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/montelukast-for-mild-moderate-parkinsons-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/morphine-study-in-obesity-and-sleep-apnea-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mother-trial-low-dose-morphine-for-cesarean-section-pain</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mpox-booster-vaccine-fractional-vs-full-dose</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mpox-vaccination-study-mpox-vax</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mrsa-treatment-povidone-iodine-nasal-kit</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/msc-therapy-for-kidney-transplant-recipients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/msp-2020-effects-on-brain-activity-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucopolysaccharidosis-iiia-gene-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucopolysaccharidosis-type-ii-dnl310-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucopolysaccharidosis-type-ii-dnl310-vs-idursulfase</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucopolysaccharidosis-type-ii-jr-141-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucopolysaccharidosis-type-iiia-jr-441-infusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucosal-melanoma-anti-pd1-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucositis-in-metastatic-renal-cell-carcinoma-folic-acid-supplement-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mucositis-prevention-dexpanthenol-mouth-rinse</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multifocal-motor-neuropathy-dnth103-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multifocal-motor-neuropathy-empasiprubart-vs-ivig</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-68ga-ga-pentixafor-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-abbv-383-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-abbv-453-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-and-knee-surgery-apixaban-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-anitocabtagene-autoleucel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-anti-bcma-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-azd0305-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-belantamab-mafodotin-and-venetoclax-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-belantamab-mafodotin-vs-daratumumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-belantamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-bgb-11417-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-bms-986453-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-cc-92480-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-comparing-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-elranatamab-and-lenalidomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-elranatamab-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-elranatamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-elranatamab-vs-standard-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-etentamig-and-iberdomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-etentamig-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-etentamig-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-etentamig-with-cancer-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-fluciclovine-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-hdp-101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-huvr-cartemis-1-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-hyqvia-for-infection-prevention</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-iberdomide-vs-lenalidomide-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-iberdomide-with-isatuximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-innovative-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-and-lenalidomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-with-belumosudil-and-dexamethasone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-with-evorpacept-and-dexamethasone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-isatuximab-with-novel-agents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-jnj-79635322-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-jnj-79635322-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-jnj-87562761-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-ktx-1001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-linvoseltamab-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-linvoseltamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-mezigdomide-vs-pomalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-new-car-t-cell-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-new-treatment-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-sable-study-with-selinexor</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-selinexor-with-dexamethasone-and-bortezomib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-teclistamab-with-daratumumab-or-lenalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-teclistamab-with-lenalidomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-testing-isb-2001</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-tg01-qs-21-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-tnb-383b-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-treatment-free-interval-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-myeloma-venetoclax-and-dexamethasone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-abp-692-vs-ocrevus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-annual-vs-semi-annual-ocrelizumab-infusions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-biib091-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-cbd-for-sleep-quality</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-cd19-targeted-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-disodium-cromoglycate-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-frexalimab-vs-teriflunomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ifenprodil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-immune-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-imu-838-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-in-kids-ofatumumab-and-siponimod-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-masitinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-obe-cel-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ocrelizumab-access-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ocrelizumab-serum-monitoring</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ozanimod-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ozanimod-vs-fingolimod</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-personalized-ocrelizumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-rituximab-vs-ocrelizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-ro7121932-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-siponimod-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-spasticity-bms-986368-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-subcutaneous-vs-intravenous-ublituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-thc-cbd-oral-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-sclerosis-treatment-withdrawal-study-for-older-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/multiple-system-atrophy-lu-af82422-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/muscle-invasive-bladder-cancer-erdafitinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/muscle-invasive-bladder-cancer-new-treatment-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myasthenia-gravis-nmd670-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myasthenia-gravis-rituximab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myasthenia-gravis-rozanolixizumab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mycobacterium-abscessus-optimizing-lung-disease-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mycobacterium-avium-complex-lung-infections-comparing-antibiotics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/mycobacterium-xenopi-infection-arikayce-inhalation-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelodysplastic-syndrome-oral-azacitidine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelodysplastic-syndrome-targeted-treatment-after-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelodysplastic-syndromes-elritercept-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelodysplastic-syndromes-ivosidenib-vs-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelodysplastic-syndromes-oral-astx030-vs-subcutaneous-azacitidine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-and-essential-thrombocythemia-inca033989-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-incb057643-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-navtemadlin-with-ruxolitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-roginolisib-with-ruxolitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-selinexor-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-study-of-pacritinib-vs-standard-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-tasquinimod-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myelofibrosis-testing-rvu120</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloid-diseases-dfv890-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloid-malignancies-bgb-11417-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloid-malignancies-pf-08046040-sea-cd70</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloma-68ga-ga-pentixafor-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloma-treatment-elranatamab-vs-daratumumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myeloma-treatment-sar446523-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myocarditis-anakinra-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myoclonic-astatic-epilepsy-fenfluramine-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myomectomy-misoprostol-for-reducing-blood-loss</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myopia-in-children-atropine-eyedrops-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonia-treatment-mexiletine-pr-vs-mexiletine-ir</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-long-term-study-of-mexiletine-pr</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-mexiletine-pr-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-type-1-atx-01-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-type-1-dyne-101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-type-1-vx-670-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/myotonic-dystrophy-type-i-metformin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nalmefene-for-reducing-cravings-in-behavioral-addictions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/narcolepsy-and-idiopathic-hypersomnia-alks-2680-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/narcolepsy-and-idiopathic-hypersomnia-orx750-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/narcolepsy-safety-study-of-lu-ah69593</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/narsoplimab-for-children-with-high-risk-stem-cell-transplant-complications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nasal-treatment-hy-133-bacteriophage-endolysin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nasopharyngeal-cancer-nivolumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nasopharyngeal-carcinoma-imaging-study-with-68ga-ga-dota-toc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/navepegritide-for-growth-in-adolescents-with-achondroplasia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nbi-1076986-safety-and-effects-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nebivolol-for-high-blood-pressure-in-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nebulized-fentanyl-facial-vs-intranasal-delivery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neoadjuvant-chemo-immunotherapy-for-stage-iii-pd-l1-positive-nsclc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neonatal-hypoxic-ischemic-encephalopathy-cord-blood-stem-cell-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neonatal-otc-deficiency-ecur-506-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neovascular-age-related-macular-degeneration-ai-assisted-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neovascular-age-related-macular-degeneration-faricimab-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neovascular-age-related-macular-degeneration-port-delivery-system-with-ranibizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neovascular-amd-faricimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nephrogenic-diabetes-insipidus-amiloride-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nephrotic-syndrome-ketoanalogues-for-muscle-preservation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nephrotic-syndrome-rituximab-treatment-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nerve-damage-from-cancer-new-immunotherapy-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neural-stem-cell-treatment-for-amyotrophic-lateral-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroblastoma-177lu-dotatate-therapy-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroblastoma-abtl0812-treatment-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroblastoma-comparing-pet-ct-and-spect-ct-scans</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroblastoma-innovative-stem-cell-transplant-and-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurocritical-patients-inhalation-vs-intravenous-sedation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurodegenerative-disease-continued-access-to-latozinemab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurodegenerative-disorders-tau-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-neoplasms-advanced-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-neoplasms-metronomic-temozolomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-tumors-177lu-edotreotide-vs-everolimus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-tumors-lutathera-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-tumors-personalized-vs-standard-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroendocrine-tumors-sauna-trial-on-somatostatin-analogues</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurogenic-inflammation-trpa1-activation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurogenic-orthostatic-hypotension-fludrocortisone-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neuroinflammation-in-major-depressive-disorder-infladep-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neurotrophic-keratopathy-rgn-259-eye-drops</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/neutropenia-mavorixafor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nevoid-basal-cell-carcinoma-syndrome-sonidegib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-imaging-tracer-for-liver-and-gi-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-method-for-umbilical-vein-catheterization-in-newborns</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-surgical-treatment-for-wet-amd-vitrectomy-and-tpa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-t-cell-therapy-for-pediatric-blood-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-treatment-for-limbal-stem-cell-deficiency-oral-mucosa-cells</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-treatment-for-patients-with-xxx-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/new-treatment-for-primary-cns-lymphoma-optimizing-matrix</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nicotinamide-for-liver-fibrosis-in-type-2-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nicotinamide-for-opa1-dominant-optic-atrophy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nicotine-pouch-vs-nicorette-r-lozenge-in-smokers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/niemann-pick-disease-type-c-n-acetyl-l-leucine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/niemann-pick-type-c-and-gm1-gm2-gangliosidosis-nizubaglustat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nintedanib-for-nosebleeds-in-hereditary-hemorrhagic-telangiectasia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nipocalimab-for-children-with-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nipocalimab-for-chronic-inflammatory-demyelinating-polyneuropathy-cidp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nipocalimab-for-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nipocalimab-for-pregnancies-at-risk-of-severe-hemolytic-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/niraparib-long-term-safety-study-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nirogacestat-understanding-its-effects-in-healthy-men</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nitroglycerin-for-esophageal-food-impaction</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nivolumab-and-entinostat-for-high-risk-cancers-in-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nivolumab-for-alk-anaplastic-large-cell-lymphoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nk-cell-infusion-for-sarcoma-in-young-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nodal-t-cell-lymphoma-duvelisib-vs-gemcitabine-or-bendamustine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-alcoholic-steatohepatitis-namodenoson-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-functioning-pituitary-adenomas-cabergoline-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-hodgkin-lymphoma-bms-986458-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-hodgkin-lymphoma-epcoritamab-with-anti-cancer-agents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-hodgkin-lymphoma-glpg5101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-hodgkin-lymphoma-iph6501-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-hodgkin-lymphoma-new-car-t-cell-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-ischemic-dilated-cardiomyopathy-secret-hf-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-seminomatous-germ-cell-tumors-personalized-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-68ganota-anti-mmr-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-acasunlimab-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-alectinib-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-amivantamab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-bms-986504-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-bnt327-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-cemiplimab-and-tedopi-r-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-cemiplimab-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-cemiplimab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-chemotherapy-plus-osimertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-divarasib-with-other-therapies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-drug-sequencing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-ds-1062a-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-fianlimab-and-cemiplimab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-furmonertinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-immunotherapy-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-mb12-vs-keytruda</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-neoadjuvant-and-adjuvant-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-new-treatment-combinations-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-osimertinib-with-datopotamab-deruxtecan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-ql2107-vs-keytruda-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-rmc-6236-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-rmc-9805-and-rmc-6236-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-sigvotatug-vedotin-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-sotorasib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-stx-721-pfl-721-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-tiragolumab-and-atezolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-u3-1402-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-small-cell-lung-cancer-v940-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-squamous-lung-cancer-pembrolizumab-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-st-elevation-acute-coronary-syndrome-aspirin-omission-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-transfusion-dependent-thalassemia-luspatercept-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/non-transfusion-dependent-thalassemia-mitapivat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nonadvanced-systemic-mastocytosis-bezuclastinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/noncardiac-surgery-noradrenaline-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nonsegmental-vitiligo-ritlecitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/norfloxacin-for-portal-hypertension-in-decompensated-cirrhosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/novel-amino-acid-pet-tracer-18f-felp</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/npm1-mutated-acute-myeloid-leukemia-eltanexor-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nras-mutant-melanoma-naporafenib-trametinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nstemi-treatment-aspirin-vs-aspirin-and-fondaparinux</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nts-521-safety-study-in-adults-and-elderly</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ntx-1955-co2-challenge-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ntx-1955-effects-on-brain-function</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nucresiran-for-transthyretin-amyloidosis-with-cardiomyopathy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nutrition-timing-after-major-abdominal-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nuwiq-for-managing-bleeding-in-hemophilia-a-patients-during-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nuwiq-for-women-and-girls-with-hemophilia-a-needing-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/nvdx3-implant-long-term-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ny-eso-1-t-cells-for-synovial-sarcoma-and-liposarcoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/o3r-5671-pro-tolerance-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obesity-bi-456906-vs-semaglutide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obesity-in-adolescents-semaglutide-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obesity-pf-07976016-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obesity-surgery-opioid-sparing-care-pathway</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obesity-treatment-orforglipron-tablet-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obsessive-compulsive-disorder-pramipexole-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obstructive-colon-cancer-neoadjuvant-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obstructive-sleep-apnea-nacystelyn-inhaler-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/obstructive-sleep-apnea-sulthiam-and-oral-appliance-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/octaplex-for-major-bleeding-in-patients-on-blood-thinners</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ocular-melanoma-roginolisib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ocular-myasthenia-gravis-corticosteroids-and-rituximab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ofatumumab-in-breast-milk-a-study-for-lactating-women-with-ms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oligometastatic-colorectal-cancer-optimise-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oligometastatic-non-small-cell-lung-cancer-immunotherapy-with-local-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oligometastatic-peritoneal-gastric-cancer-pipac-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oligometastatic-prostate-cancer-lu-psma-and-radiotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oligometastatic-solid-cancer-sbrt-with-atra-support</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/olmsted-syndrome-km-023-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/om85-for-preventing-respiratory-infections-in-elderly-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/omalizumab-withdrawal-in-severe-allergic-asthma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/omx-0407-for-unresectable-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ongoing-safety-study-for-patients-in-previous-trials</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ongoing-treatment-with-durvalumab-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/onychomycosis-dexulac-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oocyte-cryopreservation-random-start-ovarian-stimulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oocyte-donation-corifollitropin-alfa-vs-daily-rfsh</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/open-angle-glaucoma-citicoline-eye-drops</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/open-heart-surgery-parasternal-block-for-pain-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/opioid-dependency-treatment-suboxone-vs-methadone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/opioid-induced-bowel-dysfunction-naldemedine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/opioid-induced-respiratory-depression-naloxone-and-nalmefene-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/opioid-use-disorder-daridorexant-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/optic-pathway-glioma-chf6467-eye-drops</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oral-arsenic-for-low-risk-myelodysplastic-syndromes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oral-midazolam-for-patients-refusing-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oral-propranolol-for-preventing-eye-issues-in-premature-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oral-vancomycin-for-primary-sclerosing-cholangitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ore-001-for-underweight-elderly-individuals</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/organ-transplantation-custodiol-n-vs-custodiol-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oropharyngeal-cancer-comparing-treatment-options</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/orthopedic-surgery-intraoperative-methadone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osimertinib-tagrisso-continuation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoarthritis-behind-the-kneecap-nasal-cartilage-implantation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoarthritis-in-the-thumb-comparing-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoarthritis-of-the-knee-sar446959-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoarthritis-safety-of-lipiodol-embolization</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoarthritis-walking-rehabilitation-with-anti-inflammatory-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteogenesis-imperfecta-losartan-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteogenesis-imperfecta-romosozumab-vs-bisphosphonates</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoporosis-dasatinib-and-quercetin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoporosis-treatment-the-optimist-study-on-romosozumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteoporosis-zoledronate-after-denosumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/osteosarcoma-mifamurtide-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ot-a201-for-blood-cancers-and-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/out-of-hospital-cardiac-arrest-danohca-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/outpatient-surgery-dexmedetomidine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-and-breast-cancer-zavatar-test-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-and-lung-cancer-tub-040-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-5-ala-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-68ga-fapi-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-com701-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-continued-treatment-with-olaparib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-diagnosis-improcas-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-hipec-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-mirvetuximab-soravtansine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-mirvetuximab-soravtansine-with-bevacizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-niraparib-and-abemaciclib-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-niraparib-and-dostarlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-niraparib-maintenance-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-niraparib-rechallenge-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-olaparib-and-bevacizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-olaparib-and-durvalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-olaparib-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-olaparib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-parp-inhibitor-with-cisplatin-and-heat-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-pembrolizumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-raludotatug-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-regn5668-with-cemiplimab-or-regn4018</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-relapse-hyperthermic-intraperitoneal-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-rinatabart-sesutecan-rina-s-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-sacituzumab-tirumotecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-salvovar-trial-on-chemotherapy-regimens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-sentinel-lymph-node-technique-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-tinzaparin-and-biomarkers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-treatment-carboplatin-and-mirvetuximab-soravtansine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-cancer-zn-c3-and-niraparib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-stimulation-follitropin-delta-and-dydrogesterone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-stimulation-for-poor-responders-cfa-vs-modified-natural-cycles</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-stimulation-in-older-women-inovee-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ovarian-stimulation-methods-for-embryo-accumulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/overactive-bladder-in-children-bedry-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxybutynin-for-boys-with-posterior-urethral-valves</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-levels-at-birth-the-hilo-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-management-during-anesthesia-the-lowox-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-supply-after-non-cardiac-surgery-aiolos-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-support-methods-for-high-risk-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-therapy-for-acute-pulmonary-embolism</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxygen-therapy-for-aecopd-standard-vs-targeted-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxytahane-oxygen-therapy-for-dystonic-attacks-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxytocin-and-trust-learning-in-attachment-development</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxytocin-for-children-with-autism-and-intellectual-disabilities</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxytocin-infusion-effects-on-sensory-nerves</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/oxytocin-treatment-for-autism-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ozone-therapy-for-chemotherapy-induced-pain-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ozone-treatment-for-numbness-from-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-after-colorectal-surgery-continuous-wound-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-dexmedetomidine-for-nerve-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-in-dental-emergencies-methoxyflurane-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-in-heart-surgery-interpectoral-pectoserratus-block</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-in-hernia-surgery-tap-block-vs-local-infiltration</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-management-in-laparoscopic-colorectal-surgery-comparing-two-techniques</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-measurement-nefopam-and-oxycodone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-medication-tapering-for-persistent-spinal-pain</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-relief-after-esophageal-procedure-levobupivacaine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-relief-for-first-degree-perineal-tears-emla-cream-vs-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pain-relief-for-kids-fentanyl-vs-ketamine-vs-morphine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/painful-diabetic-peripheral-neuropathy-vx-993-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/painful-venous-malformations-apixaban-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/palmo-plantars-warts-hpv-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/palmoplantar-pustulosis-delgocitinib-cream-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pamidronate-for-pain-in-sternocostoclavicular-hyperostosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreas-and-kidney-transplant-sirolimus-vs-mycophenolate-mofetil</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-and-bile-duct-cancer-68ga-fapi-46-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-antiplatelet-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-ceb-01-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-digitoxin-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-durvalumab-and-rintatolimod-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-folfirinox3-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-folfox-vs-gemcitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-gembrax-and-folfirinox-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-gembrax-with-folfirinox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-gemcitabine-vs-reduced-dose-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-hyperpolarized-pyruvate-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-islet-cell-transplantation-after-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-kisima-02-vaccine-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-mfolfirinox-with-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-nabpaclitaxel-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-napabucasin-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-neoadjuvant-triple-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-new-electroporation-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-new-treatment-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-organoid-based-treatment-selection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-personalized-folfirinox-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-sgm-101-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-short-vs-long-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-sotorasib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-tcr-modified-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-testing-enzyme-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-cancer-trametinib-and-hydrochloroquine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-exocrine-insufficiency-creon-r-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-exocrine-insufficiency-creon-r-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-head-cancer-neoadjuvant-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pancreatic-lung-breast-and-colorectal-cancers-177lu-lu-nns309</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/panguian-clinical-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/papillary-craniopharyngioma-dabrafenib-and-trametinib-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/papillary-renal-cell-carcinoma-axitinib-with-or-without-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/papulopustular-acne-clindamycin-tretinoin-gel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/paracetamol-brain-effects-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-aav2-gdnf-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-aci-7104-056-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-biib122-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-cvn424-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-investigational-drug-arv-102</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-lecigon-r-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-new-approaches-to-levodopa-resistance</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-new-investigational-compound</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinson-s-disease-safinamide-vs-rasagiline-for-fatigue</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinsons-disease-and-multiple-system-atrophy-exidavnemab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinsons-disease-ro7568282-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parkinsons-disease-vs-multiple-system-atrophy-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/paroxysmal-nocturnal-hemoglobinuria-pozelimab-and-cemdisiran-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/parp-pet-imaging-in-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/partial-lipodystrophy-metreleptin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pasireotide-for-synovial-sarcoma-and-desmoplastic-small-round-cell-tumor</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pasireotide-injection-methods-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/patellofemoral-osteoarthritis-nasal-cartilage-implant-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/patent-ductus-arteriosus-paracetamol-treatment-in-premature-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/patient-controlled-sedation-for-perineal-laceration-repair</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/patritumab-deruxtecan-for-pediatric-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pbp1510-for-advanced-pancreatic-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pcos-fertility-letrozole-vs-gonadotropins</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pd-1-antibody-for-metastatic-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pda-treatment-in-premature-infants-acetaminophen-and-ibuprofen-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pediatric-cancer-crizotinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pediatric-hepatic-tumor-trial-evaluating-treatments-for-hepatoblastoma-and-hepatocellular-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pediatric-hip-surgery-tranexamic-acid-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pegcetacoplan-for-adolescents-with-paroxysmal-nocturnal-hemoglobinuria</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pegozafermin-for-metabolic-dysfunction-associated-steatohepatitis-mash</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pelizaeus-merzbacher-disease-ion356-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pembrolizumab-for-advanced-adrenocortical-carcinoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pembrolizumab-for-children-with-advanced-melanoma-and-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pembrolizumab-for-progressive-multifocal-leukoencephalopathy-in-immunocompromised-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pemigatinib-for-solid-tumors-with-fgfr-alterations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pemphigus-personalized-treatment-strategy-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/penile-and-tongue-cancer-new-imaging-technique</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/penile-cancer-carboplatin-paclitaxel-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/penile-rehabilitation-after-prostate-cancer-surgery-pehab-ii</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peptide-receptor-radionuclide-therapy-la-ssa-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/perennial-allergic-rhinitis-lebrikizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/perianal-crohns-disease-fapi-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/perianal-fistulas-regenerative-cell-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/periodontitis-vitamin-d3-supplementation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-arterial-disease-new-imaging-agent-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-t-cell-lymphoma-lacutamab-with-gemox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-t-cell-lymphoma-lis1-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-t-cell-lymphoma-new-drug-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-t-cell-lymphoma-new-drug-evaluation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peripheral-t-cell-lymphoma-tolinapant-with-decitabine-cedazuridine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peritonitis-treatment-pentaglobin-r-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/persistent-atrial-fibrillation-cryoballoon-vs-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/persistent-corneal-epithelial-defects-nexagon-gel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/personalized-anti-platelet-therapy-for-coronary-artery-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/personalized-treatment-for-high-risk-breast-cancer-petremac-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peyronie-s-disease-fapi-pet-ct-and-fdg-pet-ct-scans</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/peyronie-s-disease-study-of-bacterial-collagenase</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pf-07940369-tolerance-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pf-07985631-tolerance-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pf-07999415-tolerance-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pik3ca-related-overgrowth-spectrum-alpelisib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/placental-vascularization-study-contrast-ultrasound</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-and-eczema-rls-1496-cream</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-bimekizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-bimekizumab-vs-topical-corticosteroids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-esk-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-in-teens-deucravacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-jnj-77242113-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-jnj-77242113-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-oral-piclidenoson-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-tak-279-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plaque-psoriasis-zasocitinib-vs-deucravacitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plasmablastic-lymphoma-daratumumab-with-bortezomib-and-dexamethasone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/platysma-prominence-nt-201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pleural-empyema-surgery-vs-drainage</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pleural-mesothelioma-ivonescimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pleural-mesothelioma-new-chemotherapy-and-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pleural-mesothelioma-pembrolizumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pleural-mesothelioma-volrustomig-with-carboplatin-and-pemetrexed</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/plozasiran-for-severe-hypertriglyceridemia-shasta-5-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pm14-treatment-for-soft-tissue-sarcomas-and-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pmm2-cdg-glm101-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumococcal-vaccine-response-age-and-hiv-impact</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumococcal-vaccine-response-in-lymph-nodes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumococcal-vaccine-response-in-patients-without-a-spleen</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumococcal-vaccine-study-for-infants-pcv21</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumonia-in-preschool-children-amoxicillin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumonia-prevention-20-valent-pneumococcal-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pneumonia-tad-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polycystic-kidney-disease-gsk4771261-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polycystic-ovary-syndrome-letrozole-vs-gonadotropins-for-insemination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polycythemia-vera-givinostat-vs-hydroxyurea</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polymyalgia-rheumatica-hydrocortisone-supplement-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polymyalgia-rheumatica-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polymyalgia-rheumatica-secukinumab-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polymyalgia-rheumatica-secukinumab-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/polypoidal-choroidal-vasculopathy-faricimab-injections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pomalidomide-for-chronic-hepatitis-b-infection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pompe-disease-enzyme-replacement-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ponatinib-for-pediatric-leukemias-and-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/portosinusoidal-vascular-disorder-edoxaban-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/posaconazole-for-fungal-infection-prevention-in-stem-cell-transplant-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/posaconazole-for-young-children-with-fungal-infections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-cardiac-arrest-shock-high-dose-vitamin-c-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-covid-19-condition-plitidepsin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-covid-19-syndrome-vericiguat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-menopausal-osteoporosis-bp16-vs-eu-prolia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-stroke-pain-understanding-nerve-roles</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-stroke-spasticity-dry-needling-vs-botulinum-toxin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-surgery-pain-management-comparing-two-techniques</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-surgery-pain-management-ropivacaine-concentration-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-surgical-hypoparathyroidism-indapamide-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/post-traumatic-stress-disorder-testing-new-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postmenopausal-bone-health-everolimus-and-exercise-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-management-after-cardiac-surgery-nsaids-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-management-fentanyl-nasal-spray</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-management-genetic-testing-for-tramadol</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-relief-after-hip-surgery-intrathecal-morphine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-relief-high-dose-dexamethasone-for-lung-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-relief-ibuprofen-and-tramadol-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-pain-relief-peng-block-for-hip-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-recovery-spinal-morphine-vs-intravenous-lidocaine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postoperative-sleep-quality-dexsleep-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/postpartum-anemia-iv-vs-oral-iron-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/posttraumatic-headache-botulinum-toxin-a-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pramipexole-for-anhedonic-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prazosin-absorption-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prca-treatment-isatuximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preclinical-alzheimer-s-disease-jnj-64042056-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prednisolone-transfer-in-breast-milk-a-study-for-breastfeeding-mothers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prednisone-for-idiosyncratic-hepatotoxicity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preeclampsia-intervention-4-metformin-for-preterm-preeclampsia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/premature-ejaculation-bp1-4979-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-abscesses-after-appendicitis-surgery-alpaca-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-blood-clots-regn9933-and-regn7508-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-bronchopulmonary-dysplasia-new-treatment-for-preterm-newborns</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-c-difficile-infections-oral-vancomycin-for-stem-cell-transplant-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-chemotherapy-induced-nausea-in-children-iv-nepa-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-constipation-after-hip-surgery-laxative-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-dementia-metformin-and-lifestyle-changes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-diabetes-after-kidney-transplant-glp-1-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-diabetes-after-kidney-transplant-glp-1-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-hearing-loss-acou085-for-testicular-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-heart-issues-in-cancer-patients-empagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-infections-after-hysterectomy-azithromycin-vs-cefuroxime</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-infections-in-icu-patients-with-interferon-gamma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-opioid-induced-constipation-in-advanced-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-pancreatic-fistulas-botulinum-toxin-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-postoperative-pain-in-children-locoregional-analgesia-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-relapses-in-minimal-change-nephrotic-syndrome-with-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/preventing-second-cancers-dostarlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-adrenal-insufficiency-plenadren-vs-cortisone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-aldosteronism-18f-ceto-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-aldosteronism-68ga-ga-pentixafor-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-aldosteronism-baxdrostat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-aldosteronism-new-imaging-technique-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-biliary-cholangitis-bezafibrate-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-biliary-cholangitis-golexanolone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-central-nervous-system-lymphoma-mtr2-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-cold-agglutinin-disease-anx1502-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-hyperoxaluria-dcr-phxc-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-iga-nephropathy-long-term-study-of-iptacopan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-iga-nephropathy-ro7434656-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-immune-thrombocytopenia-belantamab-mafodotin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-immune-thrombocytopenia-efgartigimod-iv-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-membranous-nephropathy-zanubrutinib-vs-tacrolimus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-plasma-cell-leukemia-ari0002h-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-plasma-cell-leukemia-new-treatment-with-bortezomib-and-daratumumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-progressive-multiple-sclerosis-adipose-stem-cell-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-sclerosing-cholangitis-norucholic-acid-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/primary-sjogren-s-disease-efgartigimod-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/procizumab-for-critical-cardiovascular-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progesterone-for-preventing-preterm-birth-in-women-with-placenta-previa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-glioblastoma-perampanel-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-multiple-sclerosis-imu-838-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-pulmonary-fibrosis-fapi-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-pulmonary-fibrosis-inhaled-pirfenidone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-pulmonary-fibrosis-inhaled-treprostinil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-supranuclear-palsy-18f-pi-2620-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/progressive-vitiligo-anifrolumab-and-phototherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prolonged-grief-disorder-pex010-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prolonged-seizures-staccato-alprazolam-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/propionic-acidemia-mrna-3927-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/propofol-injection-pain-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/propranolol-for-anxiety-in-pancreatic-cancer-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prosetin-for-amyotrophic-lateral-sclerosis-als</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-12-month-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-177lu-psma-617-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-177lu-psma-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-225ac-ac-psma-r2-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-225ac-psma-i-t-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-aaa617-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-abemaciclib-with-abiraterone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-abiraterone-and-oxycodone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-adt-with-darolutamide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-amg-509-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-androgen-deprivation-therapy-and-psma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-apalutamide-with-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-apalutamide-with-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-atorvastatin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-azd5305-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-bms-986365-vs-standard-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-cc-1-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-darolutamide-addition-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-diagnosis-18f-psma-pet-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-ebastine-with-docetaxel-or-cabazitaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-enzalutamide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-estradiol-and-exercise-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-hifu-and-hormone-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-imaging-99mtc-mip-1404-spect-ct-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-imaging-psma-pet-vs-mpmri</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-intermittent-vs-continuous-hormone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-jsb462-and-lutetium-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-long-term-safety-of-lutetium-177lu-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-lutetium-177-vs-standard-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-metastasis-directed-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-neoadjuvant-treatment-with-177lu-lu-psma-617</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-neoadjuvant-xaluritamig-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-new-radioactive-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-new-treatment-approach-with-hormone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-new-treatment-combining-radiation-and-antiandrogen</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-pembrolizumab-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-personalized-radiotherapy-and-hormone-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-pf-06821497-with-enzalutamide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-radium-223-and-docetaxel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-re-treatment-with-177lu-lu-psma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-recurrence-psma-pet-ct-vs-salvage-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-ro7656594-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-saruparib-and-darolutamide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-short-vs-long-term-androgen-deprivation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-surgery-with-darolutamide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-treatment-docetaxel-vs-androgen-receptor-targeted-agents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-upar-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-cancer-vir-5500-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prostate-medication-and-gut-health-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/protecting-children-from-radiation-induced-hypothyroidism</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prt7732-for-advanced-solid-tumors-with-smarca4-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prucalopride-for-refractory-gastro-esophageal-reflux-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prurigo-nodularis-barzolvolimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/prurigo-nodularis-povorcitinib-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pseudomyxoma-peritonei-neoadjuvant-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-assisted-therapy-for-severe-alcohol-use-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-for-cancer-related-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-for-chemotherapy-induced-pain-relief</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-for-depression-in-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-for-hospitalized-patients-with-treatment-resistant-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psilocybin-therapy-for-depression-in-serious-illnesses</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriasis-18f-fluoride-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriasis-in-children-idp-122-lotion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriasis-investigational-skin-products</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriasis-management-proactive-drug-monitoring-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriasis-treatment-ckd-704-vs-skyrizi-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-and-axial-spondyloarthritis-sonelokimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-guselkumab-for-enthesitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-jnj-77242113-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-lutikizumab-and-risankizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-sonelokimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-sonelokimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-tapering-immunosuppressive-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psoriatic-arthritis-zasocitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psychiatric-disorders-immunotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/psychosis-in-alzheimer-s-iti-1284-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-inhaled-gb002-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-ltp001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-ralinepag-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-seralutinib-inhalation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-sotatercept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-treprostinil-palmitil-inhalation-powder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-treprostinil-sodium-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-arterial-hypertension-triple-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-aspergillosis-mirage-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-embolism-surveillance-vs-anticoagulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-fibrosis-long-term-study-of-bi-1015550</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-hypertension-long-term-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-hypertension-mosliciguat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-hypertension-sotatercept-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-hypertension-tx000045-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-sarcoidosis-oatd-01-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-sarcoidosis-xtmab-16-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pulmonary-tuberculosis-cysteamine-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/pyridoxine-for-primary-sclerosing-cholangitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/quabodepistat-understanding-liver-function-impact</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/quizartinib-for-newly-diagnosed-flt3-itd-negative-acute-myeloid-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/quizartinib-for-pediatric-flt3-itd-positive-aml</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ra0127-first-in-human-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rabies-vaccine-pain-and-usability-study-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/radial-nerve-block-opioid-tolerant-individuals</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/radiprodil-for-children-with-grin-related-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/radiprodil-for-seizures-in-tuberous-sclerosis-and-focal-cortical-dysplasia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rapamycin-cream-for-port-wine-stains</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rapamycin-for-drug-resistant-epilepsy-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rar-immune-nivolumab-ipilimumab-vs-pazopanib-for-advanced-sarcoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rare-cancers-dendritic-cell-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rare-cancers-targeted-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rare-ovarian-cancer-abemaciclib-and-letrozole-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ras-g12c-mutated-non-small-cell-lung-cancer-rmc-6291-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ravulizumab-dosing-for-pnh-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ravulizumab-for-children-with-nmosd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ravulizumab-for-pediatric-iga-nephropathy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ray121-safety-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/raynauds-phenomenon-sodium-thiosulfate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rcs-21-safety-study-in-healthy-volunteers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/reclaim-treatments-for-long-covid</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recombinant-factor-viia-for-acute-hemorrhagic-stroke</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recovery-after-gallbladder-surgery-esmolol-vs-sufentanil</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-adenocarcinoma-contact-x-ray-brachytherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-atezolizumab-and-bevacizumab-after-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-ferumoxtran-10-mri-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-nanoecho-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-regorafenib-and-nivolumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-surgery-sgm-101-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-treatment-comparing-therapies-for-older-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-cancer-valproic-acid-with-radiotherapy-and-capecitabine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rectal-polyps-sgm-101-fluorescent-tracer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-brain-tumors-in-children-ultrasound-blood-brain-barrier-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-diverticulitis-mbk-01-capsules</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-glioblastoma-ipilimumab-and-nivolumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-glioblastoma-personalized-drug-strategy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-grade-4-glioma-bortezomib-and-temozolomide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-gynecological-cancers-imgn151-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-herpes-labialis-lipovir-r-gel-vs-zovirax-r-cream</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-low-grade-serous-ovarian-cancer-avutometinib-and-defactinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-lower-respiratory-tract-infections-buccalin-tablets</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-meningioma-177lu-lu-dotatate-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-miscarriages-premi-trial-on-prednisolone</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-or-metastatic-solid-tumors-i-dxd-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-ovarian-cancer-olaparib-vs-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-pericarditis-in-children-anakinra-vs-steroids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-prostate-cancer-spectracure-p18-system-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-solid-cancer-pep-010-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-solid-tumors-ima402-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/recurrent-solid-tumors-obt076-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/reducing-anxiety-in-children-multimedia-vs-midazolam</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/reducing-complications-after-pancreatoduodenectomy-hop-bundle-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/reducing-radiation-in-pet-scans-below-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-b-cell-autoimmune-diseases-cnty-101-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-epilepsy-ycj-01-cannabis-extract</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-focal-onset-epilepsy-bhv-7000-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-focal-onset-epilepsy-bhv-7000-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-generalized-myasthenia-gravis-kyv-101-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-heart-failure-dapagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-invasive-pulmonary-aspergillosis-nebulized-pc945</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-schizophrenia-naben-r-with-clozapine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/refractory-solid-tumors-propranolol-and-vinorelbine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/regorafenib-for-recurrent-grade-2-and-3-meningioma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-multiple-myeloma-daratumumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-or-refractory-pcnsl-emavusertib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-or-refractory-tumors-acse-esmart-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-primary-cns-lymphoma-high-dose-methotrexate-with-glucarpidase</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-refractory-aml-venetoclax-and-decitabine-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsed-refractory-t-cell-leukemia-cd7-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-cyb704-vs-ocrevus</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-obexelimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-remibrutinib-vs-ocrelizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-remibrutinib-vs-teriflunomide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-rituximab-vs-ocrelizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-multiple-sclerosis-ytb323-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relapsing-remitting-multiple-sclerosis-ozanimod-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/relatlimab-and-nivolumab-for-young-lymphoma-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rem0045392-new-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/remdesivir-for-covid-19-in-kidney-transplant-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/remifentanil-for-intubation-in-newborns</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/remyelination-in-multiple-sclerosis-pet-mr-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/renal-impairment-enpatoran-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/renal-lifecycle-trial-dapagliflozin-for-severe-chronic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/repotrectinib-for-advanced-cancers-in-kids-and-young-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/res-010-for-overweight-and-moderately-obese-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/retinitis-pigmentosa-gs030-gene-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/retinitis-pigmentosa-new-treatment-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/retinitis-pigmentosa-stem-cell-eye-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/retinoblastoma-new-conservative-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/retinoblastoma-new-treatment-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rett-syndrome-leriglitazone-study-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rett-syndrome-testing-mirtazapine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rezafungin-for-chronic-pulmonary-aspergillosis-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rezafungin-for-fungal-infections-in-critically-ill-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rhabdomyosarcoma-new-treatment-combinations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-abatacept-and-daratumumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-abatacept-vs-tnf-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-abo21009-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-adalimumab-tapering-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-and-sjogren-s-disease-rapcabtagene-autoleucel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-ap1189-with-methotrexate</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-baricitinib-and-anti-tnf-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-car-t-therapy-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-cit-013-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-cln-978-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-f8il10-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-fbl-mtx-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-gs-0151-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-imvt-1402-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-jak-inhibitor-dose-tapering-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-lower-dose-of-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-ly3871801-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-methmax-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-methotrexate-and-novobiocin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-new-biosimilar-drug-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-precision-therapy-using-biomarkers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-prednisolone-tapering-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-proactive-drug-monitoring-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-rituximab-tapering-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-spironolactone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-study-of-pit565</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-targeted-therapy-vs-triple-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rheumatoid-arthritis-tulisokibart-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rhizarthrosis-autologous-stromal-vascular-fraction-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ribociclib-for-cancer-patients-continued-access-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/richter-s-syndrome-m-chop-with-mosunetuzumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/richter-syndrome-glofitamab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/richter-transformation-testing-new-combination-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/right-heart-failure-dapagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/riluzole-for-spinocerebellar-ataxia-type-7</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rimegepant-for-migraine-effects-on-obesity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/risankizumab-for-moderate-to-severe-plaque-psoriasis-in-children-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rituximab-for-amyotrophic-lateral-sclerosis-als</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rituximab-for-children-with-nephrotic-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rituximab-for-heart-attack-recovery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rituximab-for-progressive-interstitial-lung-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ro7504109-immune-cell-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rod-cone-dystrophy-spvn06-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ros1-positive-lung-cancer-repotrectinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rosacea-treatment-ivermectin-cream-vs-soolantra</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rosuvastatin-for-preventing-venous-thromboembolism-recurrence</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rotator-cuff-disease-botulinum-toxin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/roxadustat-for-anemia-in-children-with-chronic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/roxadustat-impact-on-heart-and-metabolism</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rr001-gene-therapy-for-locally-advanced-pancreatic-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rsv-hospitalization-prevention-abrysvo-r-vaccine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rsv-immunization-study-nirsevimab-for-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rsv-vaccination-in-stem-cell-transplant-recipients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/rsv-vaccine-study-for-immunocompromised-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ruxolitinib-for-children-with-hemophagocytic-lymphohistiocytosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ruxolitinib-rollover-study-for-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/s-aureus-bacteremia-cloxacillin-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/s-ketamine-for-severe-acute-brain-injury</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sacituzumab-govitecan-with-bevacizumab-for-brain-metastases-in-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sacubitril-valsartan-for-arrhythmogenic-right-ventricular-cardiomyopathy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sacubitril-valsartan-for-heart-protection-in-breast-cancer-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/safety-study-of-aic263029-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/safety-study-of-ax-5006-in-parkinson-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/safety-study-of-imp761-immunosuppressive-antibody</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/safety-study-of-nrg5051-in-parkinson-s-disease-and-als</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sage-319-safety-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/salivary-duct-carcinoma-dutasteride-with-combined-androgen-blockade</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sapho-syndrome-etanercept-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sarcoidosis-oral-sirolimus-for-facial-skin-involvement</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sarcomas-new-treatment-approach-with-ddr-inhibition</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sarcopenia-treatment-nandrolone-and-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sasanlimab-for-muscle-invasive-bladder-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/satralizumab-for-pediatric-neuromyelitis-optica-spectrum-disorder</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scabies-treatment-comparing-permethrin-creams</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scabies-treatment-comparison-permethrin-vs-ivermectin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scabies-treatment-testing-permethrin-cream</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scarred-vocal-folds-autologous-fat-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-and-alcohol-use-disorder-tirzepatide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-biomarkers-for-clozapine-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-cariprazine-for-cognitive-function</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-intensified-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-spectrum-disorders-oxytocin-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/schizophrenia-treatment-cannabidiol-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scleroderma-related-lung-disease-investigational-treatments</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scleroderma-stem-cell-injections-for-digital-ulcers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/scoliosis-surgery-pooled-plasma-vs-crystalloid</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sdl-m1-nanoparticles-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/seasonal-allergic-rhinitis-pq-grass-treatment-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/secukinumab-long-term-safety-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sedation-in-older-critically-ill-patients-dexmedetomidine-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sedation-in-preterm-infants-dexmedetomidine-vs-midazolam</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sedation-methods-in-tavr-procedures</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sedation-study-remimazolam-vs-midazolam-for-gi-endoscopy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/seizure-treatment-after-cardiac-arrest-telstar-2-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/seizures-in-developmental-and-epileptic-encephalopathies-lp352-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/seizures-in-developmental-and-epileptic-encephalopathy-bexicaserin-lp352</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/self-administration-of-elranatamab-for-multiple-myeloma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-acute-ischemic-stroke</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-glucose-intolerance-in-women-with-prior-gestational-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-mood-improvement-in-depression</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-obesity-and-resistant-hypertension</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-reducing-gi-issues-in-chemotherapy-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/semaglutide-for-weight-loss-in-low-responders-after-bariatric-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/seminomas-eden-study-on-reduced-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/senicapoc-for-progressive-fibrotic-interstitial-lung-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sens-501-for-children-with-hearing-loss-from-otoferlin-mutations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sentinel-node-biopsy-icg-99mtc-nanoscan-tracer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-associated-acute-kidney-injury-tin816-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-induced-hypotension-regn7544-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-treatment-aminoglycoside-antibiotics-and-isolation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-treatment-hydrocortisone-and-fludrocortisone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-treatment-meropenem-vs-piperacillin-tazobactam</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sepsis-treatment-new-antibiotic-dosing-strategy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-comparing-sodium-lactate-and-saline-solutions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-early-use-of-vasopressin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-ivabradine-for-heart-rate-control</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-landiolol-infusion-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-levetiracetam-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/septic-shock-mesenchymal-stem-cells-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/serious-bacterial-infections-in-children-aztreonam-avibactam-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/serotonin-and-decision-making-a-behavioral-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/setmelanotide-for-rohhad-syndrome</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-acute-pain-eskape-study-on-low-dose-ketamine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-alcohol-associated-hepatitis-int-787-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-asthma-dupilumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-asthma-predicting-response-to-benralizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-asthma-tezepelumab-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-asthma-tezepelumab-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-asthma-verekitug-upb-101-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-autoimmune-diseases-cd19-targeted-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-autoimmune-encephalitis-bortezomib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-brain-injury-apomorphine-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-community-acquired-pneumonia-aon-d21-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-corneal-ulcers-nanoulcor-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-depression-ketamine-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-diffuse-cutaneous-systemic-sclerosis-rapcabtagene-autoleucel-vs-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-eosinophilic-asthma-benralizumab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-epilepsy-cannabidiol-oral-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-functional-disorders-duloxetine-and-patient-education</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-hemophilia-a-continued-access-to-efanesoctocog-alfa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-hemophilia-a-efanesoctocog-alfa-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-hyponatremia-ddavp-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-infections-in-icu-comparing-antibiotics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-infections-modify-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-influenza-dexamethasone-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-influenza-early-oseltamivir-carboxylate-levels</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-pneumonia-testing-trimodulin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-spasticity-botulinum-toxin-type-a-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-systemic-lupus-erythematosus-belimumab-and-rituximab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-systemic-lupus-erythematosus-obecabtagene-autoleucel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-systemic-sclerosis-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-vitamin-d-deficiency-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-von-willebrand-disease-new-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/severe-von-willebrand-disease-vonicog-alfa-prophylaxis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sglt-2-inhibitors-for-elderly-patients-with-type-2-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/shingrix-vaccine-safety-in-psoriasis-and-psoriatic-arthritis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/short-bowel-syndrome-antibiotic-absorption-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/short-bowel-syndrome-crofelemer-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/short-bowel-syndrome-hm15912-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/short-course-antibiotics-for-gram-negative-bacteremia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/short-term-insomnia-neurexan-r-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/shoulder-surgery-benzoyl-peroxide-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-and-b-thalassemia-ctx001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-bms-986470-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-ctx001-treatment-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-etavopivat-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-gene-therapy-with-lovocel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-hydroxycarbamide-tablets-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-disease-tebapivat-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sickle-cell-pain-relief-intranasal-sufentanil-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sildenafil-for-adults-with-univentricular-heart-post-fontan</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/simvastatin-for-primary-sclerosing-cholangitis-psc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sinonasal-carcinoma-pembrolizumab-and-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sinusitis-treatment-azithromycin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/siponimod-for-progressive-multiple-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sjogren-s-syndrome-stem-cell-treatment-for-dry-mouth</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sjogrens-disease-sibeprenlimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sjogrens-syndrome-deucravacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-cancer-treatment-nivolumab-and-relatlimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-cancer-treatment-the-bless-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-candidiasis-mecloderm-r-ointment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-immune-response-syx-5219-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-inflammation-and-antibiotic-effectiveness-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/skin-irritation-study-new-5-lidocaine-plaster</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sleeping-through-menopause-hormone-therapy-and-online-sleep-support</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-bowel-adenocarcinoma-folfirinox-vs-folfox</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-177lu-evg321-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-68ga-evg321-diagnostic-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-al8326-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-bi-764532-dosing-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-bi-764532-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-bi-764532-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-bi-764532-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-durvalumab-and-olaparib-maintenance-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-durvalumab-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-etoposide-free-chemotherapy-with-durvalumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-mk-6070-and-ifinatamab-deruxtecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-niraparib-with-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-sacituzumab-govitecan-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-tarlatamab-combination-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-trilaciclib-vs-placebo</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/small-cell-lung-cancer-zl-1310-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sod1-als-amt-162-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sodium-bicarbonate-for-cardiac-arrest-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sodium-thiosulfate-injections-for-ectopic-calcifications</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-doxorubicin-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-intensified-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-mek-and-pdl1-inhibitor-combination</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-oral-cyclophosphamide-vs-doxorubicin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-pembrolizumab-with-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcoma-trabectedin-with-ttf-ngr</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcomas-atezolizumab-with-radiotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcomas-hdm201-and-pazopanib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/soft-tissue-sarcomas-int230-6-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-cancers-ni-1801-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-cancers-nilk-2401-antibody-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-177lu-lu-akir001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-68ga-fapi-46-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-azd5335-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-azd9592-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-e7386-with-other-anticancer-drugs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-genetically-modified-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-ima401-tcer-r-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-investigational-drug-the-0504</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-long-term-safety-of-brigimadlin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-mcla-128-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-mk-0472-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-mk-5684-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-necvax-neo1-with-pd-1-pd-l1-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-new-oral-anti-tumor-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-pet-imaging-of-vartumabs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-pyx-201-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-skb264-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/solid-tumors-valemetostat-tosylate-with-dxd-adcs</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sotagliflozin-for-post-bariatric-hypoglycaemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sotatercept-for-children-with-pulmonary-artery-hypertension</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sotorasib-for-advanced-lung-cancer-with-kras-g12c-mutation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sparsentan-for-pediatric-kidney-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-cord-injury-tz-161-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-muscular-atrophy-nusinersen-via-thecaflex-drx-system</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-muscular-atrophy-risdiplam-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-muscular-atrophy-risdiplam-study-for-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-muscular-atrophy-risdiplam-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinal-muscular-atrophy-ro7204239-with-risdiplam</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinocerebellar-ataxia-and-huntingtons-disease-vo659-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spinocerebellar-ataxia-sca27b-fampridine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spironolactone-for-arrhythmogenic-right-ventricular-dysplasia-arvd</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/splenic-marginal-zone-lymphoma-rituximab-with-zanubrutinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/spring-rollover-follow-up-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/squamous-cell-carcinoma-cetuximab-with-or-without-paclitaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/squamous-cell-carcinoma-of-the-penis-lymphadenectomy-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staccato-alprazolam-for-prolonged-seizures-in-ages-12-and-up</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stage-iii-lung-cancer-mk-7684a-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stage-iii-lung-cancer-surgery-and-durvalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stage-iiia-b-nsclc-new-immunotherapy-and-chemotherapy-approach</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stage-iv-non-small-cell-lung-cancer-immunotherapy-and-radiotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stage-iv-nsclc-osimertinib-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcal-joint-infection-rifampicin-vs-clindamycin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcus-aureus-bacteraemia-bensylpenicillin-vs-cloxacillin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcus-aureus-bacteremia-comparing-antibiotic-durations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcus-aureus-bacteremia-shorter-antibiotic-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcus-aureus-bacteremia-snap-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/staphylococcus-aureus-bloodstream-infections-dalbavancin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/statin-intolerance-personalized-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/statin-therapy-for-frail-older-adults-after-stroke</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/status-epilepticus-treatment-in-elderly-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stem-cell-transplant-for-children-with-acute-lymphoblastic-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stem-cell-transplant-new-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stem-cell-transplantation-vs-immunosuppressive-therapy-for-systemic-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/steroid-treatment-for-wheezing-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/steroid-withdrawal-in-systemic-lupus-erythematosus-sle</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stomach-and-pancreatic-cancer-asp2138-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stomach-cancer-mk-2870-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stop-leukemia-metformin-for-blood-disorders</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-care-hope-study-on-blood-pressure-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-prevention-aspiring-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-prevention-in-kidney-disease-apixaban-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-prevention-low-dose-colchicine-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-prevention-milvexian-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-treatment-anesthesia-vs-sedation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-treatment-intra-arterial-thrombolysis-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-treatment-study-tirofiban-vs-aspirin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/stroke-treatment-thrombolysis-for-patients-on-factor-xa-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/study-on-banned-substances-espama-3</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/subarachnoid-hemorrhage-edv2209-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sublingual-vaccine-trained-immunity-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/sufentanil-for-pain-management-in-abdominal-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/suicidal-thoughts-nitrous-oxide-treatment-in-emergencies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/surgery-and-immune-response-low-dose-interferon-alfa2a-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/surgery-fluid-study-albumin-vs-ringer-s-solution</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/surgical-site-infection-prevention-linezolid-vs-vancomycin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/survodutide-comparing-two-formulations</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-juvenile-idiopathic-arthritis-baricitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-juvenile-idiopathic-arthritis-sarilumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-azd5492-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-belimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-caba-201-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-cc-97540-car-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-cenerimod-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-dapirolizumab-pegol-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-deucravacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-esk-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-gsk4527363-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-ianalumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-obexelimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-rapcabtagene-autoleucel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-ro7507062-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-sar441344-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-lupus-erythematosus-upadacitinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-anifrolumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-associated-lung-disease-belimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-efgartigimod-ph20-sc-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-nintedanib-and-tocilizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-prevention-clopidogrel-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/systemic-sclerosis-related-lung-disease-belimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/t-cell-acute-lymphoblastic-leukemia-oc-1-car-t-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/t-cell-lymphoma-autologous-stem-cell-transplantation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/t-guard-for-early-diffuse-cutaneous-systemic-sclerosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tacrolimus-and-blood-sugar-control-in-dialysis-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tacrolimus-monotherapy-for-elderly-kidney-transplant-recipients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tafasitamab-for-pediatric-acute-b-lineage-leukemia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tailored-prom-personalized-treatment-for-preterm-premature-rupture-of-membranes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tak-330-for-reversing-blood-thinner-effects-in-urgent-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tak-881-for-primary-immunodeficiency-diseases</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/takayasu-arteritis-infliximab-vs-tocilizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/takotsubo-syndrome-beta-blockers-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/takotsubo-syndrome-cyclosporine-a-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/takotsubo-syndrome-new-treatment-approaches</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/talquetamab-reducing-oral-side-effects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tar-0520-gel-for-folliculitis-in-colorectal-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tar-0520-gel-for-preventing-nerve-damage-in-breast-cancer-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tardive-dyskinesia-safety-study-of-ade513</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tardive-dyskinesia-testing-ade513</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/targeted-anti-cancer-drugs-drup-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/targeted-anti-cancer-treatment-protarget-trial</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/targeted-therapies-for-moderate-to-severe-crohns-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tarlatamab-for-advanced-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tarlatamab-for-extensive-stage-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tau-imaging-in-alzheimer-s-comparing-pet-tracers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tavi-patients-ticagrelor-vs-aspirin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tbr1-related-neurocognitive-disorder-lithium-carbonate-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tdp-43-proteinopathies-new-imaging-agent-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/teicoplanin-dosing-optimized-vs-standard-care</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/teicoplanin-for-infection-prevention-in-pediatric-aml</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/telmisartan-for-portal-hypertension-in-liver-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/temozolomide-for-non-enhancing-adult-brainstem-gliomas</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tenosynovial-giant-cell-tumor-study-of-absk021</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/testing-cle-905-ag-for-safety-and-tolerability</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/testosterone-gel-for-improving-recovery-in-critically-ill-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/testosterone-supplementation-for-obese-men-with-type-2-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tezepelumab-for-progressive-pulmonary-fibrosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thalassemia-and-myelodysplastic-syndromes-sp-420-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thc-oil-for-chronic-neuropathic-pain</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/the-life-met-study-metformin-and-lifestyle-changes-in-early-puberty</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/theo-260-for-ovarian-cancer-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thn391-for-early-alzheimer-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/throat-and-larynx-cancer-low-dose-radiation-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thromboprophylaxis-for-advanced-germ-cell-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thrombosis-prevention-in-surgery-apixaban-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-cancer-treatment-radioiodine-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-batoclimab-extension-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-efgartigimod-ph20-sc</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-efgartigimod-ph20-sc-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-lu-ag22515-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-sirolimus-vs-corticosteroids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-tour006-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-vrdn-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/thyroid-eye-disease-vrdn-003-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tick-borne-encephalitis-novel-cytokine-release-assay</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tislelizumab-for-cancer-patients-with-residual-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tmj-arthritis-cortisone-injection-vs-arthrocentesis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/toasst-study-comparing-steroid-withdrawal-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tocilizumab-for-acute-chest-syndrome-in-sickle-cell-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tocilizumab-for-painful-chronic-pancreatitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tocolysis-for-preterm-premature-rupture-of-membranes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tolvaptan-for-children-with-autosomal-recessive-polycystic-kidney-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tonsillectomy-pain-relief-ropivacaine-vs-lidocaine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tonsillitis-treatment-antibiotic-vs-no-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tos-358-for-adults-with-solid-tumors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/total-hip-replacement-tranexamic-acid-injection</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tourette-disorder-serotonin-and-impulsivity-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tozorakimab-for-uncontrolled-asthma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tozorakimab-syringe-vs-autoinjector-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/trabectedin-for-hey1-noca2-positive-mesenchymal-chondrosarcoma</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tranexamic-acid-for-postoperative-complications-in-plastic-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tranexamic-acid-for-preventing-bleeding-in-tooth-extractions</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tranexamic-acid-for-reducing-blood-loss-in-cesarean-deliveries-with-placenta-previa</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tranexamic-acid-for-reducing-blood-transfusions-in-abdominal-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tranexamic-acid-for-spontaneous-brain-bleeding</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/transfer-factor-tfi-for-recurrent-infections</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/transfusion-dependent-b-thalassemia-and-severe-sickle-cell-disease-ctx001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/transfusion-dependent-b-thalassemia-ctx001-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/transthyretin-amyloidosis-with-cardiomyopathy-vutrisiran-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/trastuzumab-deruxtecan-t-dxd-for-unresectable-or-metastatic-her2-low-breast-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/traumatic-brain-injury-wharton-s-jelly-stem-cells</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/treatment-resistant-depression-comp360-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/treatment-resistant-depression-p-glycoprotein-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/treatment-resistant-ptsd-mifepristone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tremelimumab-injection-for-early-stage-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/trigeminal-neuralgia-botox-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-68ga-fapi-46-pet-ct-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-atezolizumab-vinorelbine-and-cyclophosphamide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-capecitabine-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-ceralasertib-with-durvalumab-and-nab-paclitaxel</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-dato-dxd-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-imatinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-keytruda-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-mk-2870-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-necvax-neo1-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-new-treatment-strategies</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-optimizing-pembrolizumab-use</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-pembrolizumab-and-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-plx038-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-sacituzumab-govitecan-and-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-sacituzumab-tirumotecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-breast-cancer-tiragolumab-and-atezolizumab-with-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-early-breast-cancer-sacituzumab-govitecan-with-or-without-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/triple-negative-metastatic-breast-cancer-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tryptobph-tryptophan-for-benign-prostatic-hyperplasia</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tuberculosis-treatment-tedizolid-vs-linezolide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tuberous-sclerosis-complex-mtor-inhibitor-treatment-in-infants</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tuberous-sclerosis-complex-vigabatrin-vs-rapamycin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tulisokibart-for-ankylosing-spondylitis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tumor-treatment-abx-001-immunotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/tumor-treatment-botensilimab-and-balstilimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/turner-syndrome-estrogen-therapy-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/turner-syndrome-oral-vs-transdermal-estrogen</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-deferoxamine-for-hypoxia-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-diamyd-r-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-diamyd-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-fenofibrate-study-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-frexalimab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-gzr33-insulin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-invited-trial-on-flu-vaccine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-low-dose-interleukin-2-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-ly3938577-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-metformin-s-impact-on-arterial-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-new-cell-therapy-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-nnc0194-0499-and-semaglutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-once-weekly-insulin-icodec-vs-daily-insulin-glargine</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-semaglutide-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-sotagliflozin-for-kidney-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-study-of-nnc0363-1063</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-1-diabetes-verapamil-treatment-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-bcaa-oxidation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-comparing-empagliflozin-pioglitazone-and-semaglutide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-dapansutrile-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-finerenone-and-sglt2-inhibitors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-insulin-nnc0471-0119-via-pump</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-ly3457263-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-nnc9733-0001-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-once-weekly-retatrutide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-personalized-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-retatrutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-ro7795081-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-ro7795081-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-semaglutide-for-bone-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-sglt-2-inhibitors-and-heart-health</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2-diabetes-vicadrostat-and-empagliflozin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-2b-von-willebrand-disease-bt200-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/type-3-spinal-muscular-atrophy-nmd670-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/udca-for-visual-recovery-after-retinal-detachment-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-adalimumab-treatment-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-and-crohn-s-disease-vedolizumab-iv-in-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-and-crohns-disease-long-term-study-of-zasocitinib</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-and-crohns-disease-vedolizumab-for-kids</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-cicr-nam-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-comparing-risankizumab-and-vedolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-comparing-ustekinumab-and-infliximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-dual-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-eltrekibart-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-encapsulated-stool-microbiome-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-filgotinib-for-kids-and-teens</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-grt-001-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-gs-1427-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-gs-5290-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-in-kids-ozanimod-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-in-kids-risankizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-in-kids-vedolizumab-vs-infliximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-lutikizumab-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-mirikizumab-with-tirzepatide</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-mk-7240-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-novel-rifamycin-enema</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-oral-mesalazine-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-ro7790121-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-ro7837195-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-sar441566-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-sar442970-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-sar443122-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-tak-279-oral-medication</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-testing-od-07656</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-tofacitinib-for-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-tofacitinib-s-impact-on-blood-clotting</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-colitis-vixarelimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-pyoderma-gangrenosum-spesolimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ulcerative-rectal-colitis-tofacitinib-response-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uncontrolled-asthma-dupilumab-vs-high-dose-ics</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uncontrolled-asthma-gsk5784283-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/understanding-abcb1-s-role-in-metoclopramide-effects</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/understanding-pain-in-parkinson-s-disease-pet-imaging-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/unilateral-retinoblastoma-adjuvant-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/unresectable-malignant-mesothelioma-tremelimumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/unruptured-intracranial-aneurysms-low-dose-aspirin-and-blood-pressure-management</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/upper-limb-spasticity-new-botulinum-toxin-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ureter-visualization-nizaracianine-triflutate-in-surgery</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urethral-stenosis-innovative-fat-injection-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urinary-incontinence-in-children-staydry-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urinary-incontinence-mesenchymal-stem-cells-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urinary-tract-infections-om-89-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urothelial-cancer-bt8009-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urothelial-cancer-ddr-gene-testing-for-chemotherapy-response</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urothelial-cancer-disitamab-vedotin-with-pembrolizumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urothelial-cancer-nivolumab-with-relatlimab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/urothelial-cancer-sacituzumab-govitecan-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/usher-syndrome-type-1b-aavb-081-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uterine-leiomyosarcoma-post-operative-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uti-vaccine-study-for-adults-aged-18-64</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uveal-melanoma-adjuvant-melatonin-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uveal-melanoma-new-liver-treatment-with-ipilimumab-and-nivolumab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uveal-melanoma-tebentafusp-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/uveitis-treatment-adalimumab-vs-mycophenolate-mofetil</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/v540a-vaccine-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/v540c-vaccine-study-in-healthy-adults</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaborem-r-for-serious-infections-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaginal-atrophy-new-estriol-vaginal-ring</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaginal-estrogen-treatment-effects-on-blood-clotting</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaginal-progesterone-for-fertility-standard-vs-new-formulation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaginal-progesterone-for-ivf-improving-live-birth-rates</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vaxxair-trial-comparing-nasal-and-injectable-flu-vaccines</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vedolizumab-for-children-with-moderate-to-severe-crohn-s-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vedolizumab-for-kids-with-ulcerative-colitis-or-crohns-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vemurafenib-for-braf-positive-juvenile-histiocytosis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/venous-leg-ulcers-escharex-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/venous-malformations-enalapril-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/venous-thromboembolism-in-cancer-abelacimab-vs-dalteparin</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/venous-ulcers-stem-cell-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ventilator-acquired-pneumonia-interferon-gamma-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ventilator-associated-pneumonia-antimicrobial-stewardship-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vericiguat-for-vasospastic-angina</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vertebral-metastases-zoledronic-acid-or-denosumab-with-radiation</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vertebral-osteomyelitis-early-oral-antibiotics-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vexas-syndrome-azacitidine-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vibegron-for-children-with-neurogenic-detrusor-overactivity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/viral-infections-after-stem-cell-transplant-multispecific-t-cell-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/viral-lung-infection-tozorakimab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/virus-specific-t-cell-therapy-for-resistant-viral-infections-post-stem-cell-transplant</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-c-treatment-for-cardiac-surgery-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d-deficiency-cholecalciferol-study-for-postmenopausal-women</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d-for-low-testosterone-in-men-with-type-2-diabetes</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d-supplementation-in-obese-children-and-adolescents</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d3-doses-in-critically-ill-patients-on-kidney-support</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d3-for-healing-after-wisdom-tooth-removal</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitamin-d3-supplementation-young-adults-vs-seniors</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitiligo-treatment-methotrexate-and-uvb-phototherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vitiligo-treatment-targeting-tyk2-responses</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/volrustomig-for-advanced-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vonafexor-acid-comparing-two-forms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vormatrigine-for-adults-with-epilepsy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vosoritide-for-growth-issues-in-children</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vulvar-cancer-chemoradiation-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vulvar-carcinoma-chemoradiation-vs-neoadjuvant-chemotherapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/vulvar-squamous-cell-carcinoma-pembrolizumab-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/waldenstroms-macroglobulinemia-venetoclax-with-rituximab</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/warm-autoimmune-hemolytic-anemia-rilzabrutinib-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wart-treatment-2lveru-r-junior-and-2lveru-r</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/weight-loss-in-hiv-semaglutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/weight-management-in-schizophrenia-semaglutide-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wheezing-in-young-children-oral-prednisolone-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/whipple-s-procedure-antibiotic-treatment-comparison</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/whooping-cough-vaccine-tdap-ipv-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wilms-tumor-metronomic-chemotherapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wilson-disease-ux701-gene-therapy-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wiskott-aldrich-syndrome-gene-therapy-follow-up</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wiskott-aldrich-syndrome-long-term-study-of-gene-therapy</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/worsening-heart-failure-cor-1167-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wrist-osteoarthritis-microfat-and-prp-injection-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wsd0922-fu-for-advanced-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/wve-007-for-adults-with-overweight-or-obesity</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/x-ald-pramipexole-for-leg-symptoms</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/x-linked-hypohidrotic-ectodermal-dysplasia-er004-treatment</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/x-linked-hypophosphatemia-kk8123-treatment-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/xen1101-for-primary-generalized-tonic-clonic-seizures</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/xenon-treatment-for-brain-injury-after-aneurysmal-subarachnoid-hemorrhage</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/yellow-fever-and-rabies-investigational-vaccines</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/yellow-fever-vaccination-comparing-injection-methods</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/ytb323-for-treatment-resistant-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zanamivir-for-infants-with-complicated-influenza</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zanidatamab-for-advanced-her2-positive-biliary-tract-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zelenectide-pevedotin-for-advanced-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zilovertamab-vedotin-for-pediatric-cancers</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zilucoplan-for-children-with-generalized-myasthenia-gravis</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zinc-acexamate-for-advanced-chronic-liver-disease</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zn-c3-for-high-grade-serous-ovarian-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zoldonrasib-for-ras-g12d-mutant-non-small-cell-lung-cancer</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zolpidem-responses-understanding-effects-in-different-patients</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
<url>
<loc>https://triallo.eu/trial/zp9830-new-medication-study</loc>
<lastmod>2026-04-05T15:34:27.977Z</lastmod>
</url>
</urlset>
